
<html lang="en"     class="pb-page"  data-request-id="c8ba05f6-0dc3-46a9-ba97-bf8f8b8a28bf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm401217d;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2013.56.issue-20"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood–Brain Barrier" /></meta><meta name="dc.Creator" content="Major  Gooyit" /></meta><meta name="dc.Creator" content="Wei  Song" /></meta><meta name="dc.Creator" content="Kiran V.  Mahasenan" /></meta><meta name="dc.Creator" content="Katerina  Lichtenwalter" /></meta><meta name="dc.Creator" content="Mark A.  Suckow" /></meta><meta name="dc.Creator" content="Valerie A.  Schroeder" /></meta><meta name="dc.Creator" content="William R.  Wolter" /></meta><meta name="dc.Creator" content="Shahriar  Mobashery" /></meta><meta name="dc.Creator" content="Mayland  Chang" /></meta><meta name="dc.Description" content="Brain metastasis occurs in 20–40% of cancer patients. Treatment is mostly palliative, and the inability of most drugs to penetrate the brain presents one of the greatest challenges in the developme..." /></meta><meta name="Description" content="Brain metastasis occurs in 20–40% of cancer patients. Treatment is mostly palliative, and the inability of most drugs to penetrate the brain presents one of the greatest challenges in the developme..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 8, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401217d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401217d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401217d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401217d" /></link>
        
    
    

<title>O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood–Brain Barrier | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401217d" /></meta><meta property="og:title" content="O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood–Brain Barrier" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0012.jpeg" /></meta><meta property="og:description" content="Brain metastasis occurs in 20–40% of cancer patients. Treatment is mostly palliative, and the inability of most drugs to penetrate the brain presents one of the greatest challenges in the development of therapeutics for brain metastasis. Matrix metalloproteinase-2 (MMP-2) plays important roles in invasion and vascularization of the central nervous system and represents a potential target for treatment of brain metastasis. Carbonate, O-phenyl carbamate, urea, and N-phenyl carbamate derivatives of SB-3CT, a selective and potent gelatinase inhibitor, were synthesized and evaluated. The O-phenyl carbamate and urea variants were selective and potent inhibitors of MMP-2. Carbamate 5b was metabolized to the potent gelatinase inhibitor 2, which was present at therapeutic concentrations in the brain. In contrast, phenyl urea 6b crossed the blood–brain barrier, however, higher doses would result in therapeutic brain concentrations. Carbamate 5b and urea 6b show potential for intervention of MMP-2-dependent diseases such as brain metastasis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401217d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401217d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401217d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401217d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401217d&amp;href=/doi/10.1021/jm401217d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8139-8150</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401211t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4012559" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><i>O</i>-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood–Brain Barrier</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Major++Gooyit">Major Gooyit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Song">Wei Song</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kiran+V.++Mahasenan">Kiran V. Mahasenan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katerina++Lichtenwalter">Katerina Lichtenwalter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++Suckow">Mark A. Suckow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valerie+A.++Schroeder">Valerie A. Schroeder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+R.++Wolter">William R. Wolter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shahriar++Mobashery">Shahriar Mobashery</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mayland++Chang">Mayland Chang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text"><sup>†</sup>Department of Chemistry and Biochemistry, <sup>‡</sup>Freimann Life Sciences Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-574-631-2965. Fax: +1-574-631-6652. E-mail: <a href="/cdn-cgi/l/email-protection#b4d9d7dcd5dad3f4dad09ad1d0c1"><span class="__cf_email__" data-cfemail="7a1719121b141d3a141e541f1e0f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401217d&amp;href=/doi/10.1021%2Fjm401217d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8139–8150</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 12, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 August 2013</li><li><span class="item_label"><b>Published</b> online</span>8 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401217d" title="DOI URL">https://doi.org/10.1021/jm401217d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8139%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMajor%2BGooyit%252C%2BWei%2BSong%252C%2BKiran%2BV.%2BMahasenan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D20%26contentID%3Djm401217d%26title%3DO-Phenyl%2BCarbamate%2Band%2BPhenyl%2BUrea%2BThiiranes%2Bas%2BSelective%2BMatrix%2BMetalloproteinase-2%2BInhibitors%2Bthat%2BCross%2Bthe%2BBlood%25E2%2580%2593Brain%2BBarrier%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8150%26publicationDate%3DOctober%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401217d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1217</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401217d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood–Brain Barrier&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Major&quot;,&quot;last_name&quot;:&quot;Gooyit&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Kiran&quot;,&quot;last_name&quot;:&quot;V. Mahasenan&quot;},{&quot;first_name&quot;:&quot;Katerina&quot;,&quot;last_name&quot;:&quot;Lichtenwalter&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. Suckow&quot;},{&quot;first_name&quot;:&quot;Valerie&quot;,&quot;last_name&quot;:&quot;A. Schroeder&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;R. Wolter&quot;},{&quot;first_name&quot;:&quot;Shahriar&quot;,&quot;last_name&quot;:&quot;Mobashery&quot;},{&quot;first_name&quot;:&quot;Mayland&quot;,&quot;last_name&quot;:&quot;Chang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;8139-8150&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401217d&quot;},&quot;abstract&quot;:&quot;Brain metastasis occurs in 20–40% of cancer patients. Treatment is mostly palliative, and the inability of most drugs to penetrate the brain presents one of the greatest challenges in the development of therapeutics for brain metastasis. Matrix metalloproteinase-2 (MMP-2) plays important roles in invasion and vascularization of the central nervous system and represents a potential target for treatment of brain metastasis. Carbonate, O-phenyl carbamate, urea, and N-phenyl carbamate derivatives of SB-3CT, a selective and potent gelatinase inhibitor, were synthesized and evaluated. The O-phenyl carbamate and urea variants were selective and potent inhibitors of MMP-2. Carbamate 5b was metabolized to the potent gelatinase inhibitor 2, which was present at therapeutic concentrations in the brain. In contrast, phenyl urea 6b crossed the blood–brain barrier, however, higher doses would result in therapeutic brain concentrations. Carbamate 5b and urea 6b show potential for intervention of MMP-2-dependent diseases suc&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401217d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401217d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401217d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401217d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401217d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401217d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401217d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401217d&amp;href=/doi/10.1021/jm401217d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401217d" /></input><a href="/doi/pdf/10.1021/jm401217d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401217d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401217d%26sid%3Dliteratum%253Aachs%26pmid%3D24028490%26genre%3Darticle%26aulast%3DGooyit%26date%3D2013%26atitle%3DO-Phenyl%2BCarbamate%2Band%2BPhenyl%2BUrea%2BThiiranes%2Bas%2BSelective%2BMatrix%2BMetalloproteinase-2%2BInhibitors%2Bthat%2BCross%2Bthe%2BBlood%25E2%2580%2593Brain%2BBarrier%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D20%26spage%3D8139%26epage%3D8150%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jmcmar.2013.56.issue-20/production/jmcmar.2013.56.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Brain metastasis occurs in 20–40% of cancer patients. Treatment is mostly palliative, and the inability of most drugs to penetrate the brain presents one of the greatest challenges in the development of therapeutics for brain metastasis. Matrix metalloproteinase-2 (MMP-2) plays important roles in invasion and vascularization of the central nervous system and represents a potential target for treatment of brain metastasis. Carbonate, <i>O</i>-phenyl carbamate, urea, and <i>N</i>-phenyl carbamate derivatives of SB-3CT, a selective and potent gelatinase inhibitor, were synthesized and evaluated. The <i>O</i>-phenyl carbamate and urea variants were selective and potent inhibitors of MMP-2. Carbamate <b>5b</b> was metabolized to the potent gelatinase inhibitor <b>2</b>, which was present at therapeutic concentrations in the brain. In contrast, phenyl urea <b>6b</b> crossed the blood–brain barrier, however, higher doses would result in therapeutic brain concentrations. Carbamate <b>5b</b> and urea <b>6b</b> show potential for intervention of MMP-2-dependent diseases such as brain metastasis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12708" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12708" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Brain metastasis is a significant health problem, occurring in 20–40% of patients with cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Patients with melanoma, lung, breast, and kidney cancer have the highest incidence of brain metastasis,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> occurring in 60–80% of patients with metastatic melanoma and representing the major cause of death in patients with melanoma.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although standard treatments for brain metastasis include surgery, radiotherapy, and chemotherapy, the prognosis is poor, with survival between 4 and 6 months<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and chemotherapy showing limited or no efficacy.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A major challenge in the development of therapeutics for brain metastasis is the poor penetration of drugs through the blood–brain barrier (BBB), and >98% of small-molecule drugs do not cross the BBB.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In addition, the presence of efflux pumps, such as P-glycoprotein, rapidly remove many drugs from the central nervous system (CNS).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Several drugs are currently being evaluated in clinical trials of patients with brain metastasis, including bevacizumab, a humanized monoclonal antivascular endothelial growth factor (VEGF) antibody that inhibits angiogenesis. However, bevacizumab is a large molecule that does not cross the BBB. Trastuzumab, a recombinant humanized human epidermal growth factor receptor 2 (HER2) monoclonal antibody that inhibits epidermal growth factor receptor (EGFR) also does not penetrate the BBB. Lapatinib, a tyrosine kinase inhibitor that targets EGFR and HER2, crosses the BBB but does not reach therapeutic concentrations in the CNS in mice.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Crizotinib is an inhibitor of anaplastic lymphoma kinase and tyrosine kinase that is being evaluated in patients with metastatic nonsmall cell lung cancer (NSCLC); however, crizotinib penetrates the brain poorly, thus hindering efficacy in metastatic brain tumors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> While strategies to improve BBB permeability,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> including disruption of the BBB, P-glycoprotein inhibitors, transcranial and transnasal delivery, and endogenous BBB transporters, have been explored, the presence of the BBB prevents potential brain metastasis drugs from reaching therapeutic levels in the brain. Thus, novel therapeutics that cross the BBB are urgently needed for the treatment of brain metastasis.</div><div class="NLM_p">Matrix metalloproteinases (MMPs) are a large group of enzymes that play important roles in many normal physiological functions such as remodeling of the extracellular matrix during development and reproduction.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> MMPs also degrade the extracellular matrix proteins that regulate processes involved in cancer progression, including cancer cell growth, apoptosis, migration, invasion, and angiogenesis.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> While MMP inhibitors have been evaluated in clinical trials for cancer,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> these studies resulted in failure primarily due to broad-spectrum inhibition of all MMPs, adverse side effects, and insufficient target validation.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Recent efforts in defining the role of particular MMPs in cancer have correlated increased expression of MMP-2 (also known as gelatinase A) with aggressive breast cancer,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> malignant prostate cancer,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> pancreatic cancer,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> gastric cancer,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> brain metastasis of melanoma,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and lung cancer brain metastasis.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Tumors expressing MMP-2 have increased vasculature at the brain–tumor interface, indicating that MMP-2 might play a role in enhancing invasion and vascularization within the CNS.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Therefore, selective MMP-2 inhibition represents a targeted therapy for the treatment of brain metastasis.</div><div class="NLM_p">The search for a selective MMP-2 inhibitor is a challenge due mainly to the high structural similarities of MMPs. We have previously reported the prototype inhibitor, SB-3CT (<b>1</b>),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> which displays a unique slow-binding mechanism of action within the active site of gelatinases (MMP-2 and MMP-9). This inhibition mode leads to a reaction involving deprotonation at the α-methylene to the sulfonyl moiety that results in ring-opening of the thiirane to provide picomolar tight-binding inhibition of gelatinases.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Compound <b>1</b> selectively inhibits the gelatinases, while sparing representative members of the other types of MMPs such as MMP-1, -3, and -7.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compound <b>1</b> is primarily metabolized at the <i>para</i>-position of the terminal phenyl ring to give a more potent gelatinase inhibitor <b>2</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> We also showed that incorporation of an amino group at the <i>para</i>-position (<b>3</b>) retained potent inhibitory activity against the gelatinases.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, in addition to gelatinases, the slow-binding kinetic profile of compounds <b>2</b> and <b>3</b> was extended to include MMP-14,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> the activator of MMP-2.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The nanomolar inhibition constants of <b>2</b> and <b>3</b> for MMP-2, MMP-9, and MMP-14 would not differentiate these three MMPs in targeting.</div><div class="NLM_p">A structure–activity relationship (SAR) study of <b>1</b> revealed that modification at the <i>para</i>-position of the terminal phenyl ring is well tolerated.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We undertook in the present study the preparation and evaluation of analogues of <b>2</b> and <b>3</b>, using functionalities such as carbonates <b>4</b>, <i>O</i>-phenyl carbamates <b>5</b>, ureas <b>6</b>, and <i>N</i>-phenyl carbamates <b>7</b>. We report herein that a distinct change in this <i>para</i> substituent led to nanomolar inhibition of only MMP-2, while sparing other MMPs, including MMP-9 and MMP-14.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0002.gif" alt="" id="GRAPHIC-d374e372-autogenerated" /></img></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88473" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88473" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The syntheses of the carbonate and carbamate derivatives of <b>2</b> are outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Carbonate derivatives <b>4a</b>–<b>d</b> were prepared in good yields by reaction of thiirane <b>2</b> with alkyl chloroformates in the presence of triethylamine. On the other hand, the syntheses of target thiiranes <b>5a</b>–<b>d</b> was initiated by Ullmann coupling of phenyl bromide <b>8</b> to phenol <b>9</b>, using CuI as catalyst, to generate the diphenyl ether <b>10</b>, which was subsequently MOM-deprotected by acid reflux to give <b>11</b>. Intermediate <i>O</i>-phenyl carbamates <b>12</b> could be easily accessed by nucleophilic addition of phenol <b>11</b> to alkyl isocyanates at reflux temperature.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Because the highly toxic methyl isocyanate is not readily available, this prompted us to explore an alternative route to the preparation of <b>12a</b>. Activation of phenol <b>11</b> with <i>p</i>-nitrophenyl (PNP)-chloroformate, followed by nucleophilic attack by methylamine, afforded the <i>N</i>-methyl carbamate <b>12a</b> in 67% yield over two synthetic steps. The succeeding steps involved oxidation to the corresponding oxiranes <b>13a</b>–<b>d</b>, and subsequent reaction with thiourea to give the desired <b>5a</b>–<b>d</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of the Carbonate and Carbamate Derivatives of <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and condition: (a) TEA, alkyl chloroformate, MeCN, 76–93%; (b) CuI, Cs<sub>2</sub>CO<sub>3</sub>, <i>N</i>,<i>N</i>-dimethylglycine HCl salt, 1,4-dioxane, 110 °C, 24 h, 83%; (c) HCl, MeOH, reflux, 1 h, 99%; (d) TEA, PNP-chloroformate, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; (e) MeNH<sub>2</sub>, THF, room temperature, 30 min, 67% from <b>11</b>; (f) TEA, alkyl isocyanate, dry toluene, reflux, 3 h, 93–98%; (g) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temperature, 6 d, 50–55%; (h) thiourea, MeOH/CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 24 h, 76–90%.</p></p></figure><div class="NLM_p">The <i>N</i>-methyl urea <b>6a</b> was prepared in a similar fashion as <i>N</i>-phenyl carbamate <b>12a</b>. An activated carbamate intermediate was first synthesized by direct coupling of thiirane <b>3</b> with PNP-chloroformate, followed by selective nucleophilic addition of methylamine to the activated carbamate to generate <b>6a</b> in 53% yield (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). A more convenient route to access asymmetric ureas is by reaction of amines with isocyanates.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Such a method was utilized to prepare urea derivatives <b>6b</b>–<b>d</b> in acceptable yields through a one-step reaction of thiirane <b>3</b> with the corresponding commercially available alkyl isocyanates in the presence of <i>N</i>-methylmorpholine. Reaction of <b>3</b> with alkyl chloroformates, using NMM as a base, readily furnished <i>N</i>-phenyl carbamates <b>7a</b>–<b>d</b> in 49–80% yield.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of the Urea and Carbamate Derivatives of <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and condition: (a) PNP-chloroformate, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; (b) MeNH<sub>2</sub>, THF, room temperature, 15 min, 53% from <b>3</b>; (c) NMM, alkyl isocyanate, THF, room temperature, 24 h, 55–61%; (d) NMM, alkyl chloroformate, THF, 0 °C, 20 min, 49–80%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> MMP Inhibition</h3><div class="NLM_p">The results of the MMP kinetics of compounds <b>4</b>–<b>7</b> are given in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Compounds <b>4</b>–<b>7</b> exhibited slow-binding inhibition of MMP-2, -9<sub>cat</sub> (catalytic domain), and -14<sub>cat</sub>, which is a distinguishing feature of the thiirane class of inhibitors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In addition, slow-binding albeit poor inhibition of MMP-8<sub>cat</sub> was observed. On the other hand, <b>4</b>–<b>7</b> showed marginal to no inhibition of MMP-1<sub>cat</sub>, -3<sub>cat</sub>, and -7. A general observation was that the entire set of inhibitors listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> exhibited comparable nanomolar potencies against MMP-2 while displaying poorer inhibition of MMP-9<sub>cat</sub> and MMP-14<sub>cat</sub>. Compounds <b>4a</b> and <b>7a</b> were the more potent MMP-9<sub>cat</sub> inhibitors among the derivatives, with inhibition constants of 0.23 ± 0.06 and 0.18 ± 0.03 μM, respectively. Analogues <b>4b</b> and <b>7b</b> showed comparable inhibition constants against MMP-9<sub>cat</sub> as ND-322 (<b>3</b>, <i>K</i><sub>i</sub> value 0.87 μM).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Carbonates <b>4</b> and <i>N</i>-phenyl carbamates <b>7</b> were 2–5-fold less potent against MMP-9<sub>cat</sub>, even less so against MMP-14<sub>cat</sub>, than MMP-2. The selectivity of inhibition of MMP-2 was more pronounced for the <i>O</i>-phenyl carbamates <b>5</b> and ureas <b>6</b>, which were at least 20-fold more active against MMP-2 than MMP-8<sub>cat</sub>, MMP-9<sub>cat</sub>, or MMP-14<sub>cat</sub>. The inhibition constants of <b>5</b> and <b>6</b> against MMP-9<sub>cat</sub> or MMP-14<sub>cat</sub> were at best 10 μM, a concentration that is less likely to be attained in vivo while retaining their nanomolar potencies against MMP-2. Hence, these compounds would find utility where MMP-2 selectivity is desired.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kinetic Parameters for Inhibition of MMPs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0005.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> is calculated from the ratio of <i>k</i><sub>off</sub>/<i>k</i><sub>on</sub>. Slow-binding kinetic parameters (<i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> values) are given in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information (Table S1)">Supporting Information (Table S1)</a>.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Catalytic domains.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Inhibition at 50 μM.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Inhibition at 30 μM.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">ND = not determined.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">NI = no inhibition at 50 μM.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Computational Analyses</h3><div class="NLM_p">We conducted computational docking of thiiranes <b>4</b>–<b>7</b> into the active sites of MMP-2, -9, and -14 to gain insight into the differences in activities against these MMPs. The S1′ cavities of these MMPs vary by the nonconserved amino acid residues lining up the pocket, which in turn alter the conformational state of the S1′ loop. Additionally, the amino acids that reside deep in the pocket have been shown to undergo significant conformational adjustment upon inhibitor binding.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The <i>para</i>-substituents of thiiranes <b>4</b>–<b>7</b> extend into the pocket, interacting differentially with the loop residues of MMP-2, MMP-9, and MMP-14. In MMP-2, the presence of relatively smaller amino acids Thr220 and Thr222 renders a sufficiently accessible S1′ pocket to accommodate <i>para</i>-substitutions of <b>4</b>–<b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). Thus, compounds <b>4</b>–<b>7</b> show similar nanomolar range of inhibition irrespective of the size of the <i>para</i>-substituents (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In comparison, the bulkier loop residue Arg424 in MMP-9 disfavors larger functional group substitutions at the <i>para</i> position. The SAR trend of MMP-9 inhibition shows that the larger size propyl and isopropyl variants produced weaker inhibition than methyl substituted analogues. In general, the weakest inhibition was observed for MMP-14 compared to MMP-2 and MMP-9 due to sterically unfavorable loop residues Gln262 and Met264 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). Although the computational analysis could rationalize the general trend in the SAR, the more pronounced loss of potency for compounds <b>5</b> and <b>6</b> against MMP-9 and MMP-14 compared to <b>4</b> and <b>7</b> could not be readily explained.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Stereo view of the thiirane analogues (<b>4b</b>, <b>5b</b>, <b>6b</b>, <b>7b</b>) docked to MMP-2 using Glide SP methodology. The ligands are represented in gray carbon capped stick representation, while MMP-2 carbon atoms and ribbons are colored aquamarine. Zn<sup>2+</sup> is depicted as a gray sphere with coordinating histidines and glutamic acid as capped sticks. Connolly surface in green was generated for MMP-2 except for the loop and zinc coordinating residues for clarity. (B) Compounds superposed to the MMP-14 crystal structure catalytic site (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2">3MA2</a>) show the bulkier amino acids Gln262 and Met264 substituted at the S1′ selectivity loop region in comparison to Thr426 and Thr428 in MMP-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Microsomal Stability and Metabolite Identification</h3><div class="NLM_p">Select compounds that showed good inhibition of MMP-9<sub>cat</sub> (<b>4b</b>, <b>7a</b>, <b>7b</b>) as well as highly MMP-2-selective analogues (<b>5b</b>, <b>6b</b>) were evaluated for metabolic stability in rat liver S9, as summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Carbonate <b>4b</b> completely hydrolyzed within 5 min to form compound <b>2</b>, which in turn had a half-life of 23.5 ± 0.5 min. Functionalization with a more stable carbamate moiety (<b>5b</b>) resulted in a half-life of 22.8 ± 1.5 min; <b>5b</b> was further converted to <b>2</b>. Three metabolites of <b>5b</b> were found: hydrolysis of the carbamate linkage to give <b>M1</b> (or compound <b>2</b>), the sulfinic acid <b>M2</b>, and thiirane <i>S</i>-oxide <b>M3</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The structures of the metabolites were proposed based on their product-ion spectra (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>); the metabolites were similar to the sulfoxides and sulfinic acids previously observed for other thiirane compounds.<a onclick="showRef(event, 'ref21 ref28'); return false;" href="javascript:void(0);" class="ref ref21 ref28">(21, 28)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Half-lives of Selected Compounds in Male Rat Liver S9</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">23.5 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">14.0 ± 2.4; 59.0 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="center">22.8 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="center">40.7 ± 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="center">17.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="center">24.8 ± 1.7</td></tr></tbody></table></div></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Metabolic Pathways of Selected Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Product-ion mass spectra of (A) parent compound <b>5b</b> and metabolites (B) <b>M1</b>, (C) <b>M2</b>, and (D) <b>M3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The half-life of <b>3</b> was observed to be biphasic, with an initial half-life of 14.0 ± 2.4 min and a 4-fold longer second-phase half-life (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The urea derivative <b>6b</b> proved to be more metabolically stable among the derivatives, with a half-life of 40.7 ± 2.2 min. The <i>O</i>-methyl carbamate <b>7a</b> had a lower metabolic stability, compared to the corresponding <i>O</i>-ethyl derivative <b>7b</b>. Carbamates <b>7a</b> and <b>7b</b> had relatively shorter half-lives of 17.6 ± 0.1 and 24.8 ± 1.7, respectively. Carbamate <b>7a</b> had similar metabolic pathways as <b>5b</b>, as illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Metabolism of <b>7a</b> led to hydrolysis of the carbamate linkage to release <b>M4</b> (or <b>3</b>), oxidation at the α-methylene to the sulfonyl group to give sulfinic acid <b>M5</b>, and thiirane sulfur oxidation to produce sulfoxide <b>M6</b>. The structures of the metabolites were proposed based on their product-ion mass spectra, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Product-ion mass spectra of (A) parent compound <b>7a</b> and metabolites (B) <b>M4</b>, (C) <b>M5</b>, and (D) <b>M6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetics and Brain Distribution of Compounds <b>5b</b> and <b>6b</b></h3><div class="NLM_p">Compounds <b>5b</b> and <b>6b</b> were selected for investigation of their pharmacokinetic properties. Because compounds <b>1</b> and <b>2</b> are readily distributed to the brain,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> the ability of compounds <b>5b</b> and <b>6b</b> to cross the BBB was also investigated. After a single subcutaneous (sc) dose of <b>5b</b> to mice, the compound was not quantifiable in plasma or brain at all time points as it was converted to <b>2</b>, an active gelatinase inhibitor. Plasma concentrations of <b>2</b> were maximal at 10 min (1.24 ± 0.676 μM), the first time point collected, and decreased to 0.114 ± 0.0147 μM at 4 h (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A and <a class="ref internalNav" href="#notes-1" aria-label="Table S2 in the Supporting Information">Table S2 in the Supporting Information</a>). Levels of compound <b>2</b> in brain were maximal at 20 min (1.35 ± 1.10 pmol/mg tissue, equivalent to 1.35 ± 1.10 μM assuming a density of 1.0 g/mL) and declined to 0.255 ± 0.0154 pmol/mg at 4 h. Brain levels remained above the <i>K</i><sub>i</sub> for MMP-2 of 6 nM at all time points. Systemic exposure (AUC<sub>0–∞</sub>) was 69.9 μM·min in plasma and 129 pmol·min/mg in brain (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>); the brain to plasma AUC ratio was 1.64, indicating that compound <b>2</b>, derived from <b>5b</b>, crossed the BBB readily.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Brain and plasma concentration–time curves of (A) compound <b>2</b> after a single 25 mg/kg sc dose of compound <b>5b</b> to mice and (B) compound <b>6b</b> after a single 25 mg/kg sc dose of compound <b>6b</b> to mice. Concentrations in pmol/mg tissue for brain and in μM for plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The urea derivative <b>6b</b> proved to be more stable and was quantifiable both in plasma and brain. Plasma and brain levels of <b>6b</b> were maximal at 10 min and were quantifiable up to 5 h, with concentrations of 0.0704 ± 0.0506 μM in plasma and 0.0133 ± 0.00337 pmol/mg in brain (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B and <a class="ref internalNav" href="#notes-1" aria-label="Table S3 in the Supporting Information">Table S3 in the Supporting Information</a>). Brain AUC<sub>0–∞</sub> was 13.8 pmol·min/mg, while that in plasma was 187 μM·min (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The brain to plasma AUC<sub>0–∞</sub> ratio of 0.0738 indicates that <b>6b</b> crosses the BBB. Levels of <b>6b</b> in brain were at all times below the <i>K</i><sub>i</sub> for MMP-2 of 0.44 μM. However, the thiirane class of inhibitors binds to MMP-2 as a thiolate generated at the active site, with <i>K</i><sub>i</sub> values in the picomolar range.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Thus, brain levels of <b>6b</b> are likely to be above the thiolate <i>K</i><sub>i</sub>, but the concentrations are not measurable by the analytical methodology. Alternatively, a dose of 100 mg/kg of compound <b>6b</b> given sc would result in brain levels above the thiirane <i>K</i><sub>i</sub>. Compound <b>6b</b> had a 3.3-fold longer elimination half-life in brain than in plasma. Hydrolysis of <b>6b</b> to give compound <b>3</b> was not observed both in plasma and brain.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters after Single Subcutaneous Dose Administration of Compound <b>5b</b> or <b>6b</b> at 25 mg/kg to Mice</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">compd <b>2</b> after dose of <b>5b</b></th><th class="rowsep1 colsep0" colspan="2" align="center">compd <b>6b</b> after dose of <b>6b</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">brain</th><th class="colsep0 rowsep0" align="center">plasma</th><th class="colsep0 rowsep0" align="center">brain</th><th class="colsep0 rowsep0" align="center">plasma</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–last</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">88.8</td><td class="colsep0 rowsep0" align="center">54.0</td><td class="colsep0 rowsep0" align="center">9.86</td><td class="colsep0 rowsep0" align="center">181</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">129</td><td class="colsep0 rowsep0" align="center">69.9</td><td class="colsep0 rowsep0" align="center">13.8</td><td class="colsep0 rowsep0" align="center">187</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2α</sub> (min)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">41.3</td><td class="colsep0 rowsep0" align="center">18.2</td><td class="colsep0 rowsep0" align="center">8.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2β</sub> (min)</td><td class="colsep0 rowsep0" align="center">533</td><td class="colsep0 rowsep0" align="center">462</td><td class="colsep0 rowsep0" align="center">204</td><td class="colsep0 rowsep0" align="center">61.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain<sub>AUC</sub>/plasma<sub>AUC</sub></td><td class="colsep0 rowsep0" colspan="2" align="center">1.64</td><td class="colsep0 rowsep0" colspan="2" align="center">0.0738</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">AUC in pmol·min/mg for brain and in μM·min for plasma.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We synthesized and evaluated carbonate, <i>O</i>-phenyl carbamate, urea, and <i>N</i>-phenyl carbamate derivatives of <b>1</b>. The <i>O</i>-phenyl carbamate and urea variants were selective and potent inhibitors of MMP-2 and poorly inhibited or showed no inhibition of MMP-1<sub>cat</sub>, MMP-3<sub>cat</sub>, MMP-7, MMP-8<sub>cat</sub>, MMP-9<sub>cat</sub>, and MMP-14<sub>cat</sub>. The ethyl <i>O</i>-phenyl carbamate <b>5b</b> was metabolized to the potent gelatinase inhibitor <b>2</b>, which was readily absorbed and distributed to the brain. Levels of compound <b>2</b> in the brain ranged from 13- to 73-fold higher than <i>K</i><sub>i</sub> for MMP-2, indicating that therapeutic concentrations were attained in the CNS. The terminal half-lives of <b>2</b> were 7.7 h in plasma and 8.9 h in brain. The phenyl urea <b>6b</b> was not hydrolyzed to compound <b>3</b>, however, <b>6b</b> crossed the BBB. However, higher doses of <b>6b</b> are required to attain therapeutic levels in the CNS. Carbamate <b>5b</b> and urea <b>6b</b> show promise for the treatment of MMP-2-dependent diseases such as brain metastases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p last">All reactions were performed under an atmosphere of nitrogen, unless noted otherwise. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Varian INOVA-500 (Varian Inc., Palo Alto, CA, USA) or Varian Unity<i>Plus</i> 300 spectrometer (Varian Inc., Palo Alto, CA, USA). Thin-layer chromatography was performed with Whatman reagents 0.25 mm silica gel 60-F plates. Flash chromatography was carried out with silica gel 60, 230–400 mesh (0.040–0.063 mm particle size) purchased from EM Science (Gibbstown, NJ, USA). High-resolution mass spectra were obtained at the Department of Chemistry and Biochemistry, University of Notre Dame, by ESI ionization, using Bruker micrOTOF/Q2 mass spectrometer (Bruker Daltonik, Bremen, Germany). Purity of the prepared compounds was generally >95%, confirmed by UPLC. Detailed conditions are given in the UPLC section.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Syntheses of the Carbonate Derivatives of <b>2</b> (<b>4a</b>–<b>d</b>)</h3><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure for the Syntheses of Thiiranes <b>4a</b>–<b>d</b></h4><div class="NLM_p">A solution of thiirane <b>2</b> (60 mg, 0.19 mmol) in acetonitrile (3 mL) was mixed with TEA (52 μL, 0.37 mmol) at ice–water temperature, followed by dropwise addition of the alkyl chloroformate (0.37 mmol). The reaction was stirred for 15 min, concentrated in vacuo, and reconstituted in EtOAc. The resulting mixture was washed with water, dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness under reduced pressure. The desired product was purified by silica gel column chromatography.</div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Methyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbonate (<b>4a</b>)</h5><div class="NLM_p last">Yield: 90%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.20 (dd, <i>J</i> = 5.14, 1.79 Hz, 1H), 2.58 (dd, <i>J</i> = 6.22, 1.67 Hz, 1H), 3.10 (dq, <i>J</i> = 7.47, 5.72 Hz, 1H), 3.17–3.31 (m, 1H), 3.56 (dd, <i>J</i> = 14.35, 5.74 Hz, 1H), 3.97 (s, 3H), 7.08–7.19 (m, 4H), 7.25–7.34 (m, 2H), 7.86–7.96 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 24.3, 26.2, 55.7, 62.7, 117.9, 121.4, 123.0, 130.9, 132.4, 148.1, 152.5, 154.3, 162.8. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>17</sub>H<sub>16</sub>NaO<sub>6</sub>S<sub>2</sub>, 403.0281; found, 403.0282.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Ethyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbonate (<b>4b</b>)</h5><div class="NLM_p last">Yield: 93%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.41 (t, <i>J</i> = 7.08 Hz, 3H), 2.16 (dd, <i>J</i> = 5.18, 1.79 Hz, 1H), 2.54 (dd, <i>J</i> = 6.08, 1.50 Hz, 1H), 3.06 (dq, <i>J</i> = 7.68, 5.68 Hz, 1H), 3.19 (dd, <i>J</i> = 14.16, 7.78 Hz, 1H), 3.48–3.56 (m, 1H), 4.34 (q, <i>J</i> = 7.18 Hz, 2H), 7.06–7.14 (m, 4H), 7.19–7.29 (m, 2H), 7.83–7.91 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 14.4, 24.4, 26.2, 62.8, 65.3, 117.9, 121.5, 123.1, 131.0, 132.4, 148.2, 152.5, 153.8, 162.9. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>18</sub>H<sub>18</sub>NaO<sub>6</sub>S<sub>2</sub>, 417.0437; found, 417.0440.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Propyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbonate (<b>4c</b>)</h5><div class="NLM_p last">Yield: 88%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.02 (t, <i>J</i> = 7.48 Hz, 3H), 1.78 (sxt, <i>J</i> = 7.14 Hz, 2H), 2.15 (dd, <i>J</i> = 5.18, 1.79 Hz, 1H), 2.53 (dd, <i>J</i> = 6.08, 1.69 Hz, 1H), 3.05 (dq, <i>J</i> = 7.35, 5.66 Hz, 1H), 3.19 (dd, <i>J</i> = 14.16, 7.78 Hz, 1H), 3.51 (dd, <i>J</i> = 14.26, 5.68 Hz, 1H), 4.23 (t, <i>J</i> = 6.68 Hz, 2H), 7.05–7.14 (m, 4H), 7.20–7.27 (m, 2H), 7.82–7.90 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 10.3, 22.1, 24.4, 26.2, 62.7, 70.7, 117.9, 121.4, 123.0, 130.9, 132.4, 148.2, 152.4, 153.8, 162.8. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>NaO<sub>6</sub>S<sub>2</sub>, 431.0594; found, 431.0565.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Isopropyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbonate (<b>4d</b>)</h5><div class="NLM_p last">Yield: 76%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.43 (d, <i>J</i> = 6.38 Hz, 6H), 2.20 (dd, <i>J</i> = 4.98, 1.79 Hz, 1H), 2.57 (dd, <i>J</i> = 6.18, 1.79 Hz, 1H), 3.03–3.14 (m, 1H), 3.22 (dd, <i>J</i> = 14.36, 7.78 Hz, 1H), 3.55 (dd, <i>J</i> = 14.26, 5.68 Hz, 1H), 5.03 (quin, <i>J</i> = 6.28 Hz, 1H), 7.08–7.16 (m, 4H), 7.23–7.31 (m, 2H), 7.86–7.94 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 21.9, 24.4, 26.3, 62.8, 73.6, 117.9, 121.5, 123.1, 131.0, 132.4, 148.3, 152.4, 153.3, 162.9. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>NaO<sub>6</sub>S<sub>2</sub>, 431.0594; found, 431.0586.</div></div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Syntheses of the Carbamate Derivatives of <b>2</b> (<b>5a</b>–<b>d</b>)</h3><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Allyl(4-(4-(methoxymethoxy)phenoxy)phenyl)sulfane (<b>10</b>)</h4><div class="NLM_p last">A mixture of compound <b>8</b> (6.5 g, 30 mmol), compound <b>9</b> (5.0 g, 30 mmol), as previously synthesized,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Cs<sub>2</sub>CO<sub>3</sub> (15 g, 46 mmol), <i>N</i>,<i>N</i>-dimethylglycine hydrochloride salt (1.3 g, 9.0 mmol), and CuI (0.85 g, 4.5 mmol) in dry 1,4-dioxane (100 mL) was heated at 110 °C for 24 h. The mixture was diluted with water and extracted with EtOAc. The combined organic layer was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by silica gel chromatography to give compound <b>10</b> in 83% yield (7.5 g). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.48 (d, <i>J</i> = 6.98 Hz, 2 H), 3.51 (s, 3 H), 5.02–5.10 (m, 2 H), 5.16 (s, 2 H), 5.81–5.93 (m, <i>J</i> = 16.92, 9.99, 6.98, 6.98 Hz, 1 H), 6.87–6.92 (m, 2 H), 6.95–7.00 (m, 2 H), 7.02–7.08 (m, 2 H), 7.32–7.36 (m, 2 H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 38.8, 56.1, 95.0, 117.6, 117.7, 118.3, 120.8, 128.6, 133.2, 134.0, 151.0, 153.7, 157.6. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>19</sub>O<sub>3</sub>S, 303.1079; found, 303.1053.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-(4-(Allylthio)phenoxy)phenol (<b>11</b>)</h4><div class="NLM_p last">To a solution of compound <b>10</b> (1.1 g, 3.6 mmol) in methanol (20 mL) was added 0.5 mL of concentrated HCl. The mixture was refluxed for 1 h, after which the solvent was evaporated to dryness. The crude product was taken up into water and EtOAc. Layers were separated, and the aqueous layer was extracted with EtOAc. The organic extracts were dried with over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification by silica gel chromatography gave the title compound in 99% yield (0.93 g). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.48 (d, <i>J</i> = 6.78 Hz, 2 H), 4.67 (s, 1 H), 5.01–5.09 (m, 2 H), 5.81–5.92 (m, <i>J</i> = 16.82, 9.65, 7.20, 7.20 Hz, 1 H), 6.79–6.85 (m, 2 H), 6.85–6.90 (m, 2 H), 6.90–6.97 (m, 2 H), 7.29–7.36 (m, 2 H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 39.0, 116.6, 117.7, 118.1, 121.3, 128.4, 133.4, 134.0, 150.0, 152.1, 158.0. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>15</sub>O<sub>2</sub>S, 259.0787; found, 259.0795.</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(4-(Allylthio)phenoxy)phenyl methylcarbamate (<b>12a</b>)</h4><div class="NLM_p last">A solution of compound <b>11</b> (0.42 g, 1.6 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was cooled in an ice–water bath and treated with TEA (0.46 mL, 3.3 mmol). PNP-chloroformate (0.41 g, 2.0 mmol) in dry THF (3 mL) was added dropwise, and the resulting mixture was stirred for 30 min. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated NH<sub>4</sub>Cl, and concentrated in vacuo. The crude intermediate (4-(4-(allylthio)phenoxy)phenyl (4-nitrophenyl) carbonate) was reconstituted in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), treated with MeNH<sub>2</sub> (2.4 mmol) in THF, and stirred for 30 min at room temperature. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with saturated NaHCO<sub>3</sub>, followed by water. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification of the crude product by silica gel chromatography gave 0.34 g (67%) of compound <b>12a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 2.86 (d, <i>J</i> = 5.02 Hz, 3H), 3.43–3.53 (m, 2H), 4.98–5.12 (m, 2H), 5.19 (q, <i>J</i> = 4.54 Hz, 1H), 5.77–5.95 (m, 1H), 6.87–7.03 (m, 4H), 7.04–7.15 (m, 2H), 7.29–7.40 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 27.8, 38.6, 117.7, 119.0, 119.8, 123.0, 129.4, 133.0, 133.8, 146.9, 154.0, 155.5, 156.7. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>18</sub>NO<sub>3</sub>S, 316.1002; found 316.1026.</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure for the Syntheses of Compounds <b>12b</b>–<b>d</b></h4><div class="NLM_p last">To a solution of <b>11</b> (0.33 g, 1.3 mmol) in dry toluene (5 mL) were added the alkyl isocyanate (1.4 mmol) and a catalytic amount of TEA (18 μL, 0.13 mmol). The mixture was refluxed for 3 h, after which the solvent was removed under reduced pressure. The desired product was purified by silica gel chromatography.</div></div><div id="sec4_1_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-(4-(Allylthio)phenoxy)phenyl Ethylcarbamate (<b>12b</b>)</h4><div class="NLM_p last">Yield: 92%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.17 (t, <i>J</i> = 7.29 Hz, 3H), 3.27 (quin, <i>J</i> = 6.88 Hz, 2H), 3.47 (d, <i>J</i> = 7.18 Hz, 2H), 4.96–5.11 (m, 2H), 5.27 (t, <i>J</i> = 5.38 Hz, 1H), 5.76–5.94 (m, 1H), 6.86–7.03 (m, 4H), 7.03–7.14 (m, 2H), 7.27–7.38 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 15.1, 36.2, 38.5, 117.6, 118.9, 119.4, 119.8, 123.0, 129.1, 129.3, 132.9, 133.8, 146.8, 156.6. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>NO<sub>3</sub>S, 330.1158; found, 330.1153.</div></div><div id="sec4_1_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(4-(Allylthio)phenoxy)phenyl propylcarbamate (<b>12d</b>)</h4><div class="NLM_p last">Yield: 95%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.94 (t, <i>J</i> = 7.41 Hz, 3H), 1.56 (sxt, <i>J</i> = 7.27 Hz, 2H), 3.09–3.27 (m, 2H), 3.47 (d, <i>J</i> = 6.94 Hz, 2H), 4.97–5.12 (m, 2H), 5.30 (t, <i>J</i> = 5.62 Hz, 1H), 5.75–5.93 (m, 1H), 6.85–7.03 (m, 4H), 7.04–7.15 (m, 2H), 7.26–7.39 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 11.3, 23.1, 38.5, 43.0, 117.6, 118.9, 119.8, 121.0, 123.0, 129.3, 132.9, 133.8, 146.9, 156.7. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>NO<sub>3</sub>S, 344.1315; found, 344.1307.</div></div><div id="sec4_1_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(4-(Allylthio)phenoxy)phenyl isopropylcarbamate (<b>12c</b>)</h4><div class="NLM_p last">Yield: 93%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.23 (d, 6H), 3.43–3.52 (m, 2H), 3.88 (dq, <i>J</i> = 13.84, 6.71 Hz, 1H), 4.96–5.14 (m, 3H), 5.76–5.94 (m, 1H), 6.85–7.03 (m, 4H), 7.04–7.14 (m, 2H), 7.27–7.38 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 22.9, 38.6, 43.5, 116.3, 117.7, 117.7, 118.9, 119.8, 121.0, 123.0, 133.0, 133.8, 146.8, 156.7. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>NO<sub>3</sub>S, 344.1315; found, 344.1313.</div></div><div id="sec4_1_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedure for the Syntheses of Oxiranes <b>13a</b>–<b>d</b></h4><div class="NLM_p">A solution of compound <b>12</b> (0.95 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was cooled in an ice–water bath and was treated with <i>m</i>-CPBA (4.8 mmol). The mixture was stirred for 1 h, warmed to room temperature, and stirred for 6 days. The suspension was filtered, and the filtrate was washed with saturated Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub>, followed by saturated NaHCO<sub>3</sub>. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The desired product was purified by silica gel column chromatography.</div><div id="sec4_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> 4-(4-((Oxiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Methylcarbamate (<b>13a</b>)</h5><div class="NLM_p last">Yield: 53%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.45 (dd, <i>J</i> = 4.79, 1.79 Hz, 1H), 2.75–2.81 (m, 1H), 2.85 (d, <i>J</i> = 4.98 Hz, 3H), 3.24–3.34 (m, 3H), 5.32 (q, <i>J</i> = 4.59 Hz, 1H), 7.00–7.10 (m, 4H), 7.11–7.17 (m, 2H), 7.80–7.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 27.8, 45.9, 45.9, 59.6, 117.5, 121.3, 123.4, 130.6, 132.5, 148.2, 151.6, 155.2, 163.0. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>17</sub>H<sub>17</sub>NNaO<sub>6</sub>S, 386.0669; found, 386.0682.</div></div><div id="sec4_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> 4-(4-((Oxiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Ethylcarbamate (<b>13b</b>)</h5><div class="NLM_p last">Yield: 52%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.17 (t, <i>J</i> = 7.28 Hz, 3H), 2.44 (dd, <i>J</i> = 4.88, 2.09 Hz, 1H), 2.69–2.81 (m, 1H), 3.20–3.32 (m, 5H), 5.40 (t, <i>J</i> = 5.58 Hz, 1H), 6.97–7.10 (m, 4H), 7.10–7.20 (m, 2H), 7.79–7.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 15.1, 36.2, 45.9, 45.9, 59.6, 117.5, 121.3, 123.4, 130.5, 132.5, 148.1, 151.5, 154.4, 162.9. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>NNaO<sub>6</sub>S, 400.0825; found, 400.0849.</div></div><div id="sec4_1_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 4-(4-((Oxiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Propylcarbamate (<b>13c</b>)</h5><div class="NLM_p last">Yield: 64%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.93 (t, <i>J</i> = 7.38 Hz, 3H), 1.56 (sxt, <i>J</i> = 7.30 Hz, 2H), 2.44 (dd, <i>J</i> = 4.79, 1.99 Hz, 1H), 2.74–2.82 (m, 1H), 3.14–3.23 (m, 2H), 3.23–3.32 (m, 3H), 5.40 (t, <i>J</i> = 5.78 Hz, 1H), 6.98–7.09 (m, 4H), 7.10–7.20 (m, 2H), 7.78–7.88 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 11.3, 23.0, 43.0, 45.9, 45.9, 59.6, 117.5, 121.3, 123.4, 130.6, 132.5, 148.2, 151.5, 154.6, 162.9. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>NO<sub>6</sub>S, 392.1162; found, 392.1153.</div></div><div id="sec4_1_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 4-(4-((Oxiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Isopropylcarbamate (<b>13d</b>)</h5><div class="NLM_p last">Yield: 50%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.21 (d, <i>J</i> = 6.38 Hz, 6H), 2.45 (dd, <i>J</i> = 4.98, 1.60 Hz, 1H), 2.74–2.82 (m, 1H), 3.22–3.34 (m, 3H), 3.86 (dq, <i>J</i> = 13.86, 6.68 Hz, 1H), 5.16 (d, <i>J</i> = 7.78 Hz, 1H), 6.98–7.10 (m, 4H), 7.15 (d, <i>J</i> = 8.77 Hz, 2H), 7.81–7.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 22.9, 43.6, 45.9, 45.9, 59.6, 117.5, 121.3, 123.5, 130.6, 132.5, 148.2, 151.6, 153.7, 163.0. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>NNaO<sub>6</sub>S, 414.0982; found, 414.1006.</div></div></div><div id="sec4_1_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> General Procedure for the Syntheses of Thiiranes <b>5a</b>–<b>d</b></h4><div class="NLM_p">To a solution of oxirane <b>13</b> (0.41 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added a mixture of thiourea (0.82 mmol) in methanol (3 mL). The resulting mixture was stirred for 24 h at room temperature, after which the solvent was removed under reduced pressure. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the suspension was filtered. The solution was concentrated in vacuo to afford the crude product, which was subsequently purified by silica gel column chromatography.</div><div id="sec4_1_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Methylcarbamate (<b>5a</b>)</h5><div class="NLM_p last">Yield: 90%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.13 (dd, <i>J</i> = 5.18, 1.79 Hz, 1H), 2.51 (dd, <i>J</i> = 6.18, 1.79 Hz, 1H), 2.86 (d, <i>J</i> = 4.98 Hz, 3H), 3.03 (dq, <i>J</i> = 7.65, 5.69 Hz, 1H), 3.18 (dd, <i>J</i> = 14.16, 7.78 Hz, 1H), 3.50 (dd, <i>J</i> = 14.16, 5.78 Hz, 1H), 5.30 (q, <i>J</i> = 4.59 Hz, 1H), 7.00–7.11 (m, 4H), 7.11–7.18 (m, 2H), 7.81–7.87 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 24.3, 26.2, 27.8, 62.6, 117.6, 121.3, 123.5, 130.8, 131.9, 148.2, 151.6, 155.2, 163.0. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>17</sub>H<sub>17</sub>NNaO<sub>5</sub>S<sub>2</sub>, 402.0440; found, 402.0448.</div></div><div id="sec4_1_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Ethylcarbamate (<b>5b</b>)</h5><div class="NLM_p last">Yield: 80%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.20 (t, <i>J</i> = 7.18 Hz, 3H), 2.14 (dd, <i>J</i> = 5.18, 1.79 Hz, 1H), 2.52 (dd, <i>J</i> = 6.18, 1.40 Hz, 1H), 3.04 (dq, <i>J</i> = 7.45, 5.76 Hz, 1H), 3.17 (dd, <i>J</i> = 14.16, 7.78 Hz, 1H), 3.24–3.36 (m, 2H), 3.51 (dd, <i>J</i> = 14.26, 5.68 Hz, 1H), 5.25 (t, <i>J</i> = 5.28 Hz, 1H), 7.08 (d, <i>J</i> = 8.77 Hz, 2H), 7.05 (d, <i>J</i> = 8.77 Hz, 2H), 7.17 (d, <i>J</i> = 8.97 Hz, 2H), 7.85 (d, <i>J</i> = 8.97 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 15.2, 24.3, 26.2, 36.3, 62.7, 117.7, 121.3, 123.5, 130.8, 132.0, 148.2, 151.7, 154.4, 163.1. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>NO<sub>5</sub>S<sub>2</sub>, 394.0777; found, 394.0798.</div></div><div id="sec4_1_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Propylcarbamate (<b>5c</b>)</h5><div class="NLM_p last">Yield: 76%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.96 (t, <i>J</i> = 7.41 Hz, 3H), 1.60 (sxt, <i>J</i> = 7.32 Hz, 2H), 2.15 (dd, <i>J</i> = 5.14, 1.79 Hz, 1H), 2.52 (dd, <i>J</i> = 5.86, 1.55 Hz, 1H), 3.00–3.10 (m, 1H), 3.15–3.29 (m, 3H), 3.52 (dd, <i>J</i> = 14.23, 5.62 Hz, 1H), 5.24 (t, <i>J</i> = 5.86 Hz, 1H), 7.00–7.13 (m, 4H), 7.13–7.22 (m, 2H), 7.80–7.89 (m, 2H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 11.4, 23.2, 24.4, 26.2, 43.1, 62.7, 76.8, 77.2, 77.7, 117.7, 121.3, 123.5, 130.9, 132.0, 148.2, 151.7, 154.6, 163.1. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>NO<sub>5</sub>S<sub>2</sub>, 408.0934; found, 408.0945.</div></div><div id="sec4_1_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl Isopropylcarbamate (<b>5d</b>)</h5><div class="NLM_p last">Yield: 87%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.21 (d, <i>J</i> = 6.58 Hz, 6H), 2.12 (dd, <i>J</i> = 5.18, 1.79 Hz, 1H), 2.50 (dd, <i>J</i> = 6.08, 1.50 Hz, 1H), 3.02 (dq, <i>J</i> = 7.38, 5.78 Hz, 1H), 3.17 (dd, <i>J</i> = 14.16, 7.78 Hz, 1H), 3.49 (dd, <i>J</i> = 14.26, 5.68 Hz, 1H), 3.86 (dq, <i>J</i> = 13.81, 6.70 Hz, 1H), 5.20 (d, <i>J</i> = 7.78 Hz, 1H), 7.06 (d, <i>J</i> = 8.77 Hz, 2H), 7.03 (d, <i>J</i> = 8.97 Hz, 2H), 7.15 (d, <i>J</i> = 8.97 Hz, 2H), 7.78–7.87 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 22.8, 24.3, 26.1, 43.5, 62.6, 117.6, 121.2, 123.5, 130.7, 131.9, 148.1, 151.5, 153.6, 163.0. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>NO<sub>5</sub>S<sub>2</sub>, 408.0934; found, 408.0957.</div></div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Syntheses of the Urea Derivatives of <b>3</b> (<b>6a</b>–<b>d</b>)</h3><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-Methyl-3-(4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)urea (<b>6a</b>)</h4><div class="NLM_p last">PNP-chloroformate (36 mg, 0.17 mmol) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and cooled in an ice–water bath. Thiirane <b>3</b> (46 mg, 0.14 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added dropwise, and the resulting mixture was stirred for 30 min in an ice–water bath. It was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated NH<sub>4</sub>Cl, and concentrated in vacuo. The crude intermediate (4-nitrophenyl (4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbamate) was reconstituted in THF (3 mL), treated with MeNH<sub>2</sub> (0.28 mmol) in THF, and stirred for 15 min at room temperature. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with saturated NaHCO<sub>3</sub>, followed by water. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification of the crude product by silica gel chromatography gave 29 mg (53%) of compound <b>6a</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 1.94 (dd, <i>J</i> = 5.08, 1.69 Hz, 1 H), 2.32 (dd, <i>J</i> = 6.18, 1.79 Hz, 1 H), 2.59 (s, 3 H), 2.77–2.86 (m, <i>J</i> = 7.40, 6.12, 6.12, 5.28 Hz, 1 H), 3.06 (dd, <i>J</i> = 14.36, 7.38 Hz, 1 H), 3.30 (dd, <i>J</i> = 14.36, 5.98 Hz, 1 H), 6.75–6.83 (m, 2 H), 6.83–6.90 (m, 2 H), 7.18–7.25 (m, 2 H), 7.59–7.66 (m, 2 H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 23.6, 25.7, 26.0, 62.3, 117.0, 120.4, 120.9, 130.5, 130.9, 137.0, 149.0, 157.3, 163.6. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>, 379.0781; found, 379.0767.</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> General Procedure for the Syntheses of Thiiranes <b>6b</b>–<b>d</b></h4><div class="NLM_p">A suspension of thiirane <b>3</b> as the HCl salt (80 mg, 0.17 mmol) in THF (3 mL) was mixed with <i>N</i>-methylmorpholine (22 μL, 0.20 mmol). The alkyl isocyanate (0.34 mmol) was added dropwise, and the reaction was stirred for 24 h at room temperature. The mixture was concentrated in vacuo and the desired urea derivative was purified by silica gel column chromatography.</div><div id="sec4_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 1-Ethyl-3-(4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)urea (<b>6b</b>)</h5><div class="NLM_p last">Yield: 61%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 0.92 (t, <i>J</i> = 7.18 Hz, 3H), 1.90 (dd, <i>J</i> = 5.08, 1.69 Hz, 1H), 2.23–2.32 (m, 1H), 2.73–2.83 (m, 1H), 2.94–3.12 (m, 3H), 3.26 (dd, <i>J</i> = 14.36, 5.98 Hz, 1H), 6.71–6.79 (m, 2H), 6.79–6.87 (m, 2H), 7.10–7.22 (m, 2H), 7.54–7.64 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 14.7, 23.5, 25.6, 34.3, 62.2, 116.8, 117.0, 120.3, 120.8, 130.3, 130.5, 130.8, 136.9, 148.9, 156.5, 163.5. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>, 393.0937; found, 393.0923.</div></div><div id="sec4_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> 1-Propyl-3-(4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)urea (<b>6c</b>)</h5><div class="NLM_p last">Yield: 58%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD): δ 0.67 (t, <i>J</i> = 7.5 Hz, 3H), 1.27 (sxt, <i>J</i> = 7.3 Hz, 2H), 1.86 (dd, <i>J</i> = 5.1, 1.7 Hz, 1H), 2.23 (dd, <i>J</i> = 6 0.2, 1.6 Hz, 1H), 2.74 (dt, <i>J</i> = 12.5, 6.1 Hz, 1H), 2.89 (t, <i>J</i> = 7.1 Hz, 2H), 3.01 (dd, <i>J</i> = 14.3, 7.5 Hz, 1H), 3.22 (dd, <i>J</i> = 14.4, 6.0 Hz, 1H), 6.64–6.75 (m, 2H), 6.76–6.83 (m, 2H), 7.11–7.18 (m, 2H), 7.52–7.58 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 10.7, 22.9, 23.3, 25.5, 41.2, 62.1, 116.8, 116.9, 120.2, 120.7, 130.3, 130.4, 130.8, 136.9, 148.8, 156.5, 163.4. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>, 407.1094; found, 407.1098.</div></div><div id="sec4_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 1-Isopropyl-3-(4-(4-((thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)urea (<b>6d</b>)</h5><div class="NLM_p last">Yield: 55%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 0.82 (d, <i>J</i> = 6.38 Hz, 6H), 1.78 (dd, <i>J</i> = 5.08, 1.69 Hz, 1H), 2.16 (dd, <i>J</i> = 6.18, 1.60 Hz, 1H), 2.62–2.69 (m, 1H), 2.91–3.01 (m, 2H), 3.15 (dd, <i>J</i> = 14.36, 6.18 Hz, 1H), 3.55 (dt, <i>J</i> = 13.11, 6.50 Hz, 1H), 6.61–6.66 (m, 2H), 6.69–6.75 (m, 2H), 7.02–7.09 (m, 2H), 7.43–7.52 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 22.2, 23.1, 25.3, 41.2, 61.9, 116.6, 116.7, 120.1, 120.6, 130.2, 130.3, 130.8, 136.8, 148.8, 155.7, 163.4. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>, 407.1094; found, 407.1114.</div></div></div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Syntheses of the Carbamate Derivatives of <b>3</b> (<b>7a</b>–<b>d</b>)</h3><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> General Procedure for the Syntheses of Thiiranes <b>7a</b>–<b>d</b></h4><div class="NLM_p">A suspension of thiirane <b>3</b> as the HCl salt (60 mg, 0.17 mmol) in THF (3 mL) was mixed with <i>N</i>-methylmorpholine (22 μL, 0.20 mmol) in an ice–water bath. The alkyl chloroformate (0.34 mmol) was added dropwise, and the reaction was stirred for 20 min. It was concentrated in vacuo and reconstituted in ethyl acetate. The resulting mixture was washed with water, dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness under reduced pressure. The desired product was purified by silica gel column chromatography.</div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Methyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbamate (<b>7a</b>)</h5><div class="NLM_p last">Yield: 80%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.16 (dd, <i>J</i> = 5.18, 1.79 Hz, 1H), 2.54 (dd, <i>J</i> = 6.18, 1.60 Hz, 1H), 3.06 (dq, <i>J</i> = 7.63, 5.70 Hz, 1H), 3.18 (dd, <i>J</i> = 14.26, 7.88 Hz, 1H), 3.52 (dd, <i>J</i> = 14.26, 5.48 Hz, 1H), 3.79 (s, 3H), 6.89 (s, 1H), 7.00–7.10 (m, 4H), 7.46 (d, <i>J</i> = 8.37 Hz, 2H), 7.82–7.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 24.4, 26.3, 52.7, 62.8, 117.5, 120.7, 121.4, 130.9, 131.8, 135.5, 150.3, 154.3, 163.4. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>17</sub>H<sub>17</sub>NNaO<sub>5</sub>S<sub>2</sub>, 402.0440; found, 402.0447.</div></div><div id="sec4_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Ethyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbamate (<b>7b</b>)</h5><div class="NLM_p last">Yield: 80%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.31 (t, <i>J</i> = 7.08 Hz, 3H), 2.15 (dd, <i>J</i> = 4.98, 1.79 Hz, 1H), 2.53 (dd, <i>J</i> = 5.98, 1.40 Hz, 1H), 3.00–3.09 (m, 1H), 3.18 (dd, <i>J</i> = 14.26, 7.88 Hz, 1H), 3.52 (dd, <i>J</i> = 14.26, 5.68 Hz, 1H), 4.23 (q, <i>J</i> = 7.18 Hz, 2H), 6.89 (s, 1H), 6.98–7.09 (m, 4H), 7.46 (d, <i>J</i> = 8.37 Hz, 2H), 7.80–7.88 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 14.7, 24.4, 26.2, 61.5, 62.8, 117.5, 120.7, 121.4, 130.9, 131.8, 135.6, 150.2, 153.9, 163.4. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>NNaO<sub>5</sub>S<sub>2</sub>, 416.0597; found, 416.0607.</div></div><div id="sec4_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Propyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbamate (<b>7c</b>)</h5><div class="NLM_p last">Yield: 76%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.98 (t, <i>J</i> = 7.38 Hz, 3H), 1.71 (sxt, <i>J</i> = 7.14 Hz, 2H), 2.16 (dd, <i>J</i> = 4.98, 1.79 Hz, 1H), 2.53 (dd, <i>J</i> = 6.18, 1.20 Hz, 1H), 3.06 (dq, <i>J</i> = 7.68, 5.75 Hz, 1H), 3.17 (dd, <i>J</i> = 14.16, 7.78 Hz, 1H), 3.53 (dd, <i>J</i> = 14.06, 5.48 Hz, 1H), 4.14 (t, <i>J</i> = 6.68 Hz, 2H), 6.84 (s, 1H), 6.99–7.09 (m, 4H), 7.46 (d, <i>J</i> = 8.57 Hz, 2H), 7.81–7.88 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 10.5, 22.4, 24.4, 26.3, 62.8, 67.2, 117.5, 120.6, 121.4, 130.9, 131.8, 135.6, 150.2, 154.0, 163.5. HRMS-ESI (<i>m</i>/<i>z</i>): [M + Na]<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>NNaO<sub>5</sub>S<sub>2</sub>, 430.0753; found, 430.0756.</div></div><div id="sec4_1_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Isopropyl (4-(4-((Thiiran-2-ylmethyl)sulfonyl)phenoxy)phenyl)carbamate (<b>7d</b>)</h5><div class="NLM_p last">Yield: 49%. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.31 (d, <i>J</i> = 6.38 Hz, 6H), 2.16 (dd, <i>J</i> = 5.08, 1.69 Hz, 1H), 2.54 (dd, <i>J</i> = 6.08, 1.50 Hz, 1H), 3.06 (dq, <i>J</i> = 7.70, 5.67 Hz, 1H), 3.17 (dd, <i>J</i> = 14.16, 7.78 Hz, 1H), 3.53 (dd, <i>J</i> = 14.16, 5.58 Hz, 1H), 4.94–5.10 (m, 1H), 6.72 (s, 1H), 6.98–7.12 (m, 4H), 7.46 (d, <i>J</i> = 8.57 Hz, 2H), 7.79–7.90 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 21.6, 22.3, 24.4, 26.3, 62.8, 117.5, 120.6, 121.4, 130.9, 131.8, 135.7, 148.3, 150.2, 163.5. HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>22</sub>NO<sub>5</sub>S<sub>2</sub>, 408.0934; found, 408.0940.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Enzyme Inhibition Studies</h3><div class="NLM_p last">Human recombinant active MMP-2 and MMP-7 and catalytic domains of MMP-3 and MMP-14 were purchased from EMD Biosciences (La Jolla, CA, USA). The catalytic domains of human recombinant MMP-1, MMP-8, and MMP-9 were from Biomol International (Plymouth Meeting, PA, USA). Fluorogenic substrate MOCAcPLGLA<sub>2</sub>pr(Dnp)AR-NH<sub>2</sub> was purchased from Peptides International (Louisville, KY, USA); MOCAcRPKPVE(Nva)WRK(Dnp)-NH<sub>2</sub>, (Dnp)P(Cha)GC(Me)HAK(NMa)NH<sub>2</sub>, and McaKPLGL(Dpa)AR-NH<sub>2</sub> were obtained from R&D Systems (Minneapolis, MN, USA). The <i>K</i><sub>m</sub> values used for the reaction of MMP-2, MMP-9<sub>cat</sub>, and MMP-14<sub>cat</sub> with the fluorogenic substrate MOCAcPLGLA<sub>2</sub>pr(Dnp)AR-NH<sub>2</sub> were 18.9 ± 1.0, 5.0 ± 0.1, and 5.6 ± 0.4 μM, respectively. The <i>K</i><sub>m</sub> value used for the reaction of MMP-8<sub>cat</sub> with the fluorogenic substrate McaKPLGL(Dpa)AR-NH<sub>2</sub> was 13.3 ± 1.89 μM. Inhibitor stock solutions (10 mM) were prepared in DMSO. The methodology for enzyme inhibition and assays was the same as reported previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Substrate hydrolysis was measured with a Cary Eclipse fluorescence spectrophotometer (Varian, Walnut Creek, CA, USA). Compounds <b>4</b>–<b>7</b> were stable in the buffers that were used in the kinetic assays.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Ultra Performance Liquid Chromatography (UPLC)</h3><div class="NLM_p last">The chromatographic system consisted of a Waters Acquity UPLC System (Waters Corporation, Milford, MA, USA) equipped with a binary solvent manager, an autosampler, a column heater, and a photodiode array detector. Samples were analyzed on an Acclaim RSLC 120 C18 column (2.2 μm, 2.1 mm i.d. × 100 mm, Dionex, Sunnyvale, CA, USA). The mobile phase consisted of elution at 0.5 mL/min with 85% A/15% B for 1 min, followed by a 6 min linear gradient to 10% A/90% B and then 10% A/90% B for 2 min (A = water; B = acetonitrile). Effluent was monitored by UV detection at 245 nm.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Multiple-Reaction Monitoring (MRM)-Mass Spectrometry</h3><div class="NLM_p last">All MRM-mass spectrometric experiments were performed with a Waters TQD tandem quadrupole detector (Milford, MA, USA) monitored with MassLynx MS software. Mass spectrometry acquisition was performed in the positive or negative electrospray ionization mode with MRM. The capillary voltage, cone voltage, extractor voltage, and RF lens voltage were set at 2.8 kV, 35 V, 3 V, and 0.3 V, respectively. Desolvation gas flow rate was 650 L/h (nitrogen). The cone gas flow rate was set at 20 L/h (nitrogen) for (+)-ESI-MRM and at 50 L/h (nitrogen) for (−)-ESI-MRM. The source temperature and desolvation temperature were held at 150 and 350 °C, respectively. Samples were analyzed on an Acclaim RSLC 120 C18 column (2.2 μm, 2.1 mm i.d. × 100 mm, Dionex, Sunnyvale, CA, USA). The mobile phase consisted of elution at 0.5 mL/min with 85% A/15% B for 1 min, followed by a 6 min linear gradient to 10% A/90% B and then 10% A/90% B for 2 min (for UPLC/(+)-ESI, A = 0.1% formic acid in water, B = 0.1% formic acid in acetonitrile; for UPLC/(−)-ESI, A = water, B = acetonitrile).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Liquid Chromatography/MicroTOF-Q II Mass Spectrometry</h3><div class="NLM_p last">The LC system consisted of a Dionex Ultimate 3000 RSLC (Dionex, Sunnyvale, CA, USA) equipped with Dionex Ultimate 3000 autosampler and Dionex Ultimate 3000 diode array detector. Mass spectrometric experiments were performed with a Bruker MicroTOF-Q II (Billerica, MA, USA) monitored with Hystar 3.2 software. Mass spectrometry acquisition was performed using electrospray ionization with the following parameters: end plate offset voltage = −0.5 kV, capillary voltage = 4.5 kV, nitrogen as both nebulizer and dry gas (8.0 L/min flow rate, 200 °C dry temperature, 4.0 bar). Samples were analyzed on an Acclaim RSLC 120 C18 column (2.2 μm, 2.1 mm i.d. × 100 mm, Dionex, Sunnyvale, CA, USA). The mobile phase consisted of elution at 0.5 mL/min with 85% A/15% B for 3 min, followed by a 9 min linear gradient to 10% A/90% B, then 10% A/90% B for 2 min (A = 0.1% formic acid in water, B = 0.1% formic acid in acetonitrile).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Microsomal Stability</h3><div class="NLM_p">Incubations consisted of male rat liver S9 (1.0 mg, BD Biosciences, Woburn, MA, USA), NADPH (0.5 mM, final concentration), and 10 μM compound (final concentration) in potassium phosphate buffer (50 mM, pH 7.4) at 37 °C in a total volume of 1 mL. Aliquots were drawn at different time points, and the reactions were terminated by addition of one volume of acetonitrile containing 1 μM of internal standard <b>14</b> or <b>15</b>, synthesized as described previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The precipitated protein was centrifuged (10 min, 10000<i>g</i>), and the supernatant was analyzed by reversed-phase UPLC/ESI-MRM. Compounds <b>2</b>, <b>4b</b>, <b>6b</b>, <b>7a</b>, <b>7b</b>, and internal standard <b>14</b> were analyzed by (−)-ESI-MRM of the transitions 321→184 for <b>2</b>, 393→321 for <b>4b</b>, 391→256 for <b>6b</b>, 378→274 for <b>7a</b>, 392→274 for <b>7b</b>, and 398→261 for <b>14</b>. Compounds <b>3</b>, <b>5b</b>, and internal standard <b>15</b> were analyzed by (+)-ESI-MRM of the transitions 322→185, 394→185, and 300→93, respectively. Peak area ratios relative to the internal standard were measured and the half-lives of the compounds in male rat liver S9 were calculated according to the first-order rate law.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0011.gif" alt="" id="GRAPHIC-d374e3491-autogenerated" /></img></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Metabolite Identification</h3><div class="NLM_p last">Compounds (50 μM of <b>5b</b> and <b>7a</b>) were incubated with rat liver S9 (1.0 mg) and 0.5 mM NADPH at 37 °C for 30 min in 50 mM potassium phosphate buffer at pH 7.4. The incubations were terminated by addition of one volume of acetonitrile. The precipitated protein was centrifuged (10 min, 13000<i>g</i>), and the supernatant was analyzed by reversed-phase LC/microTOF-Q II mass spectrometry.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Computational Method</h3><div class="NLM_p last">Coordinates of the thiirane analogues were built in Maestro v 9.3 environment and energy minimized using LigPrep v2.52. (Schrödinger LLC). MMP-2 protein structure coordinate, which was obtained from a previous study,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> was prepared for docking using the Protein Preparation Wizard protocol in Schrödinger Suite 2012. A constrained energy minimization using the OPLS2005 forcefield was carried out with a 0.30 Å RMSD convergence threshold. The docking grid was calculated for a cubic box that would allow ligands up to 20 Å length to dock at the catalytic site centered on the ligand. A core-constraint for the thiirane ring for 1 Å was enforced in the Glide SP v5.8 docking and top scoring poses were retained for further inspection.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Animals</h3><div class="NLM_p last">Mice (female C57Bl/6J, 6–8 weeks old, 16–19 g body weight, specific pathogen free, <i>n</i> = 3 per time point) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Mice were provided with Teklad 2019 Extruded Rodent Diet (Harlan, Madison, WI, USA) and water ad libitum. Animals were maintained in polycarbonate shoebox cages with hardwood bedding in a room under a 12/ h light/dark cycle and at 72 ± 2 °F. All procedures were performed in accordance with the University of Notre Dame Institutional Animal Care and Use Committee.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Animal Dosing and Sample Collection</h3><div class="NLM_p last">Compound <b>5b</b> was formulated as a solution at a concentration of 5.0 mg/mL in 10% DMSO/25% Tween 80/65% water. Compound <b>6b</b> was dissolved in 80% propylene glycol/20% DMSO. The solutions were sterilized by filtration through an Acrodisc syringe filter (Pall Life Sciences, 0.2 μm, 13 mm diameter, PTFE membrane). Mice (<i>n</i> = 3 per time point) were administered a single 100 μL subcutaneous (sc) dose of compound <b>5b</b> or <b>6b</b> (equivalent to 25 mg/kg). Terminal blood samples (<i>n</i> = 3 per time point) were collected in heparin through the posterior vena cava at specific time points. Blood samples were stored on ice and centrifuged to obtain plasma. Whole brain samples were harvested after transcardiac perfusion with saline, weighed, and immediately flash-frozen in liquid nitrogen and stored at −80 °C until analysis.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Sample Analysis</h3><div class="NLM_p">A 50 μL aliquot of plasma was mixed with 100 μL of internal standard <b>14</b> or <b>15</b> in acetonitrile to a final concentration of 5 μM. The sample was centrifuged at 20000<i>g</i> for 15 min. Brain samples were weighed and homogenized for 5 min in one volume equivalent of cold acetonitrile containing internal standard <b>14</b> or <b>15</b> using a bullet blender (Next Advance, Inc., Averill Park, NY, USA) at 4 °C. The brain homogenates were centrifuged at 20000<i>g</i> for 20 min at 4 °C. The plasma and brain supernatants were analyzed by reversed-phase UPLC/ESI-MRM of the transitions 394→320 for <b>5b</b> (positive ion), 391→256 for <b>6b</b> (negative ion), 321→184 for <b>2</b> (negative ion), 322→185 for <b>3</b> (positive ion), 398→261 (negative ion) for internal standard <b>14</b>, and 300→93 for internal standard <b>15</b>. Calibration curves of compounds <b>2</b>, <b>3</b>, <b>5b</b>, and <b>6b</b> were prepared by fortification of blank mouse plasma and blank mouse brain with compounds <b>2</b>, <b>3</b>, <b>5b</b>, and <b>6b</b> at concentrations up to 50 μM. Quantification was performed by using peak area ratios relative to the internal standard and linear regression parameters calculated from the calibration curve standards. The assay was linear from 0.05 to 5 μM, with a coefficient of determination, <i>R</i><sup>2</sup>, of 0.994 for <b>2</b> and 0.991 for <b>6b</b>.</div><div class="NLM_p last">Mass spectrometry acquisition of compound <b>2</b> was performed in the negative ESI mode with MRM. The capillary voltage, cone voltage, extractor voltage, and RF lens voltage were set at 3.0 kV, 30 V, 3 V, and 0.1 V, respectively. Desolvation gas flow rate was 450 L/h (nitrogen), and the cone gas flow rate was 50 L/h (nitrogen). The source temperature and desolvation temperature were held at 150 and 250 °C, respectively. Samples were analyzed on an Acquity BEH Shield RP 18 column (1.7 μm, 2.1 mm i.d. × 100 mm, Waters). The mobile phase consisted of elution at 0.5 mL/min with a 2 min linear gradient from 40% water/60% acetonitrile to 20% water/80% acetonitrile, followed by a 6 min linear gradient to 100% acetonitrile.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Pharmacokinetic Parameters</h3><div class="NLM_p last">The area under the mean concentration–time curve up to the last quantifiable sampling time (AUC<sub>0–last</sub>) was calculated by the trapezoidal rule using PK Solutions software version 2.0 (Summit Research Services, Montrose, CO, USA). AUC<sub>0–∞</sub> was calculated as AUC<sub>0–last</sub> + (<i>C</i><sub>last</sub>/<i>k</i>), where <i>C</i><sub>last</sub> is the concentration at the last quantifiable sampling time and <i>k</i> is the elimination rate constant. Half-lives (<i>t</i><sub>1/2α</sub> and <i>t</i><sub>1/2β)</sub> were estimated from the linear portion of the concentration–time data by linear regression, where the slope of the line is the rate constant <i>k</i> and <i>t</i><sub>1/2</sub> = ln 2/<i>k</i>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/jm401217d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Kinetic parameters for the slow-binding inhibition of MMPs; concentrations of compounds <b>2</b> and <b>6b</b> in plasma and brain.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401217d/suppl_file/jm401217d_si_001.pdf">jm401217d_si_001.pdf (174.17 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID for the TOC graphic <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2">3MA2</a> (MMP-14 coordinate), and PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CK7">1CK7</a> (MMP-2 coordinate).</p><div class="testing" data-doi="10.1021/jm401217d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mayland Chang</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8fe2ece7eee1e8cfe1eba1eaebfa"><span class="__cf_email__" data-cfemail="85e8e6ede4ebe2c5ebe1abe0e1f0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Major Gooyit</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Song</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiran V. Mahasenan</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katerina Lichtenwalter</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. Suckow</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerie A. Schroeder</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William R. Wolter</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shahriar Mobashery</span> - <span class="hlFld-Affiliation affiliation">†Department of Chemistry and Biochemistry, ‡Freimann Life Sciences
Center and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana 46556, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d374e3707-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grant CA122417 from the National Institutes of Health (to M.C. and S.M.). M.G. is a Fellow of the Chemistry–Biochemistry–Biology Interface (CBBI) Program at the University of Notre Dame, supported by training grant T32 GM075762.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i67" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i67"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> Abbreviations Used</h2><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the concentration–time curve</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term"><i>m</i>-CBPA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperbenzoic acid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">Dnp</td><td class="NLM_def"><p class="first last">2,4-dinitrophenyl</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">MOCAc</td><td class="NLM_def"><p class="first last">(7-methoxycoumarin-4-yl)acetyl</p></td></tr><tr><td class="NLM_term">MOM</td><td class="NLM_def"><p class="first last">methoxymethyl</p></td></tr><tr><td class="NLM_term">MRM</td><td class="NLM_def"><p class="first last">multiple reaction monitoring</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate reduced</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Fokas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodel, C.</span><span> </span><span class="NLM_article-title">Biology of brain metastases and novel targeted therapies: time to translate the research</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1835</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1835&publication_year=2013&pages=61-75&author=E.+Fokasauthor=J.+P.+Steinbachauthor=C.+Rodel&title=Biology+of+brain+metastases+and+novel+targeted+therapies%3A+time+to+translate+the+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFokas%26aufirst%3DE.%26aulast%3DSteinbach%26aufirst%3DJ.%2BP.%26aulast%3DRodel%26aufirst%3DC.%26atitle%3DBiology%2520of%2520brain%2520metastases%2520and%2520novel%2520targeted%2520therapies%253A%2520time%2520to%2520translate%2520the%2520research%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1835%26spage%3D61%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Barnholtz-Sloan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigneau, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, R. E.</span><span> </span><span class="NLM_article-title">Incidence proportions of brain metastases in patients diagnosed (1973–2001) in the Metropolitan Detroit Cancer Surveillance System</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1200%2FJCO.2004.12.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=15254054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2865-2872&author=J.+S.+Barnholtz-Sloanauthor=A.+E.+Sloanauthor=F.+G.+Davisauthor=F.+D.+Vigneauauthor=P.+Laiauthor=R.+E.+Sawaya&title=Incidence+proportions+of+brain+metastases+in+patients+diagnosed+%281973%E2%80%932001%29+in+the+Metropolitan+Detroit+Cancer+Surveillance+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System</span></div><div class="casAuthors">Barnholtz-Sloan Jill S; Sloan Andrew E; Davis Faith G; Vigneau Fawn D; Lai Ping; Sawaya Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2865-72</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Population-based estimates of the incidence of brain metastases are not generally available.  The purpose of this study was to calculate population-based incidence proportions (IPs) of brain metastases from single primary lung, melanoma, breast, renal, or colorectal cancer.  PATIENTS AND METHODS:  Patients diagnosed with single primary lung, melanoma, breast, renal, or colorectal cancer (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System (MDCSS) were used for analysis.  IP of brain metastases by primary site and variable of interest (race, sex, age at diagnosis of primary cancer, and Surveillance, Epidemiology, and End Results [SEER] stage of primary cancer) was calculated with 95% CIs.  RESULTS:  Total IP percentage (IP%) of brain metastases was 9.6% for all primary sites combined, and highest for lung (19.9%), followed by melanoma (6.9%), renal (6.5%), breast (5.1%), and colorectal (1.8%) cancers.  Racial differences were seen with African Americans demonstrating higher IP% of brain metastases compared with other racial groups for most primary sites.  IP% was significantly higher for female patients with lung cancer, and significantly higher for male patients with melanoma.  The highest IP% of brain metastases occurred at different ages at diagnoses: age 40 to 49 years for primary lung cancer; age 50 to 59 years for primary melanoma, renal, or colorectal cancers; and age 20 to 39 for primary breast cancer.  IP% significantly increased as SEER stage of primary cancer advanced for all primary sites.  CONCLUSION:  Total IP% of brain metastases was lower than previously reported, and it varied by primary site, race, sex, age at diagnosis of primary cancer, and SEER stage of primary cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1FltY_UquSCCEBeYuoi7AfW6udTcc2eZ3PFN4FOrUkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D&md5=76fa82deca39e5aced5f3d98735be3d0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.12.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.12.149%26sid%3Dliteratum%253Aachs%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%2BS.%26aulast%3DSloan%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DF.%2BG.%26aulast%3DVigneau%26aufirst%3DF.%2BD.%26aulast%3DLai%26aufirst%3DP.%26aulast%3DSawaya%26aufirst%3DR.%2BE.%26atitle%3DIncidence%2520proportions%2520of%2520brain%2520metastases%2520in%2520patients%2520diagnosed%2520%25281973%25E2%2580%25932001%2529%2520in%2520the%2520Metropolitan%2520Detroit%2520Cancer%2520Surveillance%2520System%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2865%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Xie, T. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershenwald, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Activation of stat3 in human melanoma promotes brain metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">3188</span><span class="NLM_x">–</span> <span class="NLM_lpage">3196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=3188-3196&author=T.+X.+Xieauthor=F.+J.+Huangauthor=K.+D.+Aldapeauthor=S.+H.+Kangauthor=M.+Liuauthor=J.+E.+Gershenwaldauthor=K.+Xieauthor=R.+Sawayaauthor=S.+Huang&title=Activation+of+stat3+in+human+melanoma+promotes+brain+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%2BX.%26aulast%3DHuang%26aufirst%3DF.%2BJ.%26aulast%3DAldape%26aufirst%3DK.%2BD.%26aulast%3DKang%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DGershenwald%26aufirst%3DJ.%2BE.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DSawaya%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DActivation%2520of%2520stat3%2520in%2520human%2520melanoma%2520promotes%2520brain%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D3188%26epage%3D3196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Preusser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilhan-Mutlu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghoff, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zielinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span> </span><span class="NLM_article-title">Brain metastases: pathobiology and emerging targeted therapies</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1007%2Fs00401-011-0933-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BC38XpslyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2012&pages=205-222&author=M.+Preusserauthor=D.+Capperauthor=A.+Ilhan-Mutluauthor=A.+S.+Berghoffauthor=P.+Birnerauthor=R.+Bartschauthor=C.+Marosiauthor=C.+Zielinskiauthor=M.+P.+Mehtaauthor=F.+Winklerauthor=W.+Wickauthor=A.+von+Deimling&title=Brain+metastases%3A+pathobiology+and+emerging+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metastases: pathobiology and emerging targeted therapies</span></div><div class="casAuthors">Preusser, Matthias; Capper, David; Ilhan-Mutlu, Ayseguel; Berghoff, Anna Sophie; Birner, Peter; Bartsch, Rupert; Marosi, Christine; Zielinski, Christoph; Mehta, Minesh P.; Winkler, Frank; Wick, Wolfgang; Deimling, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-222</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Brain metastases (BM) are common in cancer patients and are assocd. with high morbidity and poor prognosis, even after intensive multimodal therapy including resection, radiotherapy (stereotactic radiosurgery or whole brain radiotherapy) and chemotherapy.  However, advances in the understanding of the pathobiol. of BM and the development of mol. targeted agents hold promise for improved prophylaxis and therapy of BM.  Here we provide a comprehensive review of the current concepts on mechanisms of the brain-metastatic cascade involving hematogenous dissemination of tumor cells, attachment to microvessel endothelial cells, extravasation into the brain, interaction with the local microenvironment, angiogenesis and intraparenchymal proliferation.  Transendothelial migration depends on adhesion mols. such as integrins, selectins and chemokines.  Tumor cells invade the brain by degrading extracellular matrix components using heparanase and matrix metalloproteinases.  Astrocytes and microglial cells exert not only anti-, but also pro-neoplastic effects on brain-invading tumor cells.  Some tumor types (e.g. melanoma) show prominent cooption of preexisting vasculature, while other tumor types (e.g. lung cancer) tend to show early angiogenesis after brain invasion.  In this article we also critically summarize the data on currently studied targeted therapeutics in BM esp. in the context of recent preclin. data.  The most promising agents for BM patients include anti-angiogenic drugs, inhibitors of v-RAF murine sarcoma viral oncogene homolog B1 (BRAF) for BRAF V600E mutated melanoma and inhibitors of epithelial growth factor receptor for non-small cell lung cancer.  Mol. anal. of the BRAF V600E status of melanoma BM using DNA-based methods or immunohistochem. may soon enter the routine neuropathol. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8umy2B0yazLVg90H21EOLACvtfcHk0lgdpf2u6kym7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpslyrsA%253D%253D&md5=6051d737b186cde4c307ff2a91b58af7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00401-011-0933-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-011-0933-9%26sid%3Dliteratum%253Aachs%26aulast%3DPreusser%26aufirst%3DM.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DIlhan-Mutlu%26aufirst%3DA.%26aulast%3DBerghoff%26aufirst%3DA.%2BS.%26aulast%3DBirner%26aufirst%3DP.%26aulast%3DBartsch%26aufirst%3DR.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DZielinski%26aufirst%3DC.%26aulast%3DMehta%26aufirst%3DM.%2BP.%26aulast%3DWinkler%26aufirst%3DF.%26aulast%3DWick%26aufirst%3DW.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DBrain%2520metastases%253A%2520pathobiology%2520and%2520emerging%2520targeted%2520therapies%26jtitle%3DActa%2520Neuropathol.%26date%3D2012%26volume%3D123%26spage%3D205%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=54-61&author=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscher, W.</span><span> </span><span class="NLM_article-title">The blood–brain barrier and cancer: transporters, treatment, and Trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663-1674&author=J.+F.+Deekenauthor=W.+Loscher&title=The+blood%E2%80%93brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+Trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0liXHuiiKd_Bpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DLoscher%26aufirst%3DW.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520Trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Taskar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudraraju, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittapalli, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsheim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gril, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1007%2Fs11095-011-0601-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=22011930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleqsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=770-781&author=K.+S.+Taskarauthor=V.+Rudrarajuauthor=R.+K.+Mittapalliauthor=R.+Samalaauthor=H.+R.+Thorsheimauthor=J.+Lockmanauthor=B.+Grilauthor=E.+Huaauthor=D.+Palmieriauthor=J.+W.+Polliauthor=S.+Castellinoauthor=S.+D.+Rubinauthor=P.+R.+Lockmanauthor=P.+S.+Steegauthor=Q.+R.+Smith&title=Lapatinib+distribution+in+HER2+overexpressing+experimental+brain+metastases+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer</span></div><div class="casAuthors">Taskar, Kunal S.; Rudraraju, Vinay; Mittapalli, Rajendar K.; Samala, Ramakrishna; Thorsheim, Helen R.; Lockman, Julie; Gril, Brunilde; Hua, Emily; Palmieri, Diane; Polli, Joseph W.; Castellino, Stephen; Rubin, Stephen D.; Lockman, Paul R.; Steeg, Patricia S.; Smith, Quentin R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">770-781</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Lapatinib, a small mol. EGFR/HER2 inhibitor, partially inhibits the outgrowth of HER2+ brain metastases in preclin. models and in a subset of CNS lesions in clin. trials of HER2+ breast cancer.  We investigated the ability of lapatinib to reach therapeutic concns. in the CNS following 14C-lapatinib administration (100 mg/kg p.o. or 10 mg/kg, i.v.) to mice with MDA-MD-231-BR-HER2 brain metastases of breast cancer.  Drug concns. were detd. at differing times after administration by quant. autoradiog. and chromatog.  14C-Lapatinib concn. varied among brain metastases and correlated with altered blood-tumor barrier permeability.  On av., brain metastasis concn. was 7-9-fold greater than surrounding brain tissue at 2 and 12 h after oral administration.  However, av. lapatinib concn. in brain metastases was still only 10-20% of those in peripheral metastases.  Only in a subset of brain lesions (17%) did lapatinib concn. approach that of systemic metastases.  No evidence was found of lapatinib resistance in tumor cells cultured ex vivo from treated brains.  Results show that lapatinib distribution to brain metastases of breast cancer is partially restricted and blood-tumor barrier permeability is a key component of lapatinib therapeutic efficacy which varies between tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVPEpwl616crVg90H21EOLACvtfcHk0liXHuiiKd_Bpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleqsLbN&md5=93de4680e8dcd3b0ee065ac002948ab7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs11095-011-0601-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-011-0601-8%26sid%3Dliteratum%253Aachs%26aulast%3DTaskar%26aufirst%3DK.%2BS.%26aulast%3DRudraraju%26aufirst%3DV.%26aulast%3DMittapalli%26aufirst%3DR.%2BK.%26aulast%3DSamala%26aufirst%3DR.%26aulast%3DThorsheim%26aufirst%3DH.%2BR.%26aulast%3DLockman%26aufirst%3DJ.%26aulast%3DGril%26aufirst%3DB.%26aulast%3DHua%26aufirst%3DE.%26aulast%3DPalmieri%26aufirst%3DD.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DCastellino%26aufirst%3DS.%26aulast%3DRubin%26aufirst%3DS.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DLapatinib%2520distribution%2520in%2520HER2%2520overexpressing%2520experimental%2520brain%2520metastases%2520of%2520breast%2520cancer%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D770%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span> </span><span class="NLM_article-title">CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">e443</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=e443-445&author=D.+B.+Costaauthor=S.+Kobayashiauthor=S.+S.+Pandyaauthor=W.+L.+Yeoauthor=Z.+Shenauthor=W.+Tanauthor=K.+D.+Wilner&title=CSF+concentration+of+the+anaplastic+lymphoma+kinase+inhibitor+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DS.%2BS.%26aulast%3DYeo%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26atitle%3DCSF%2520concentration%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520inhibitor%2520crizotinib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3De443%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">The blood–brain barrier: bottleneck in brain drug development</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=3-14&author=W.+M.+Pardridge&title=The+blood%E2%80%93brain+barrier%3A+bottleneck+in+brain+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%253A%2520bottleneck%2520in%2520brain%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D3%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Page-McCaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewald, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases and the regulation of tissue remodelling</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1038%2Fnrm2125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=17318226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=221-233&author=A.+Page-McCawauthor=A.+J.+Ewaldauthor=Z.+Werb&title=Matrix+metalloproteinases+and+the+regulation+of+tissue+remodelling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and the regulation of tissue remodelling</span></div><div class="casAuthors">Page-McCaw, Andrea; Ewald, Andrew J.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-233</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) were discovered because of their role in amphibian metamorphosis, yet they have attracted more attention because of their roles in disease.  Despite intensive scrutiny in vitro, in cell culture and in animal models, the normal physiol. roles of these extracellular proteases have been elusive.  Recent studies in mice and flies point to essential roles of MMPs as mediators of change and phys. adaptation in tissues, whether developmentally regulated, environmentally induced or disease assocd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGsYuEMGL7Vg90H21EOLACvtfcHk0lhT19pMRYq_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D&md5=8c3655e653939cd016e2949c6b017e93</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrm2125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2125%26sid%3Dliteratum%253Aachs%26aulast%3DPage-McCaw%26aufirst%3DA.%26aulast%3DEwald%26aufirst%3DA.%2BJ.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520metalloproteinases%2520and%2520the%2520regulation%2520of%2520tissue%2520remodelling%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D221%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Egeblad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">New functions for the matrix metalloproteinases in cancer progression</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1038%2Fnrc745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=11990853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=161-174&author=M.+Egebladauthor=Z.+Werb&title=New+functions+for+the+matrix+metalloproteinases+in+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">New functions for the matrix metalloproteinases in cancer progression</span></div><div class="casAuthors">Egeblad, Mikala; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) have long been assocd. with cancer-cell invasion and metastasis.  This provided the rationale for clin. trials of MMP inhibitors, unfortunately with disappointing results.  We now know, however, that the MMPs have functions other than promotion of invasion, have substrates other than components of the extracellular matrix, and that they function before invasion in the development of cancer.  With this knowledge in hand, can we rethink the use of MMP inhibitors in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtDQGs5M_BzLVg90H21EOLACvtfcHk0lhT19pMRYq_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D&md5=56dd558362155cb25c9adbea4d478aa8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc745%26sid%3Dliteratum%253Aachs%26aulast%3DEgeblad%26aufirst%3DM.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DNew%2520functions%2520for%2520the%2520matrix%2520metalloproteinases%2520in%2520cancer%2520progression%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Devy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, D. T.</span><span> </span><span class="NLM_article-title">New strategies for the next generation of matrix-metalloproteinase inhibitors: selectively targeting membrane-anchored MMPs with therapeutic antibodies</span> <span class="citation_source-journal">Biochem. Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">191670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=191670&author=L.+Devyauthor=D.+T.+Dransfield&title=New+strategies+for+the+next+generation+of+matrix-metalloproteinase+inhibitors%3A+selectively+targeting+membrane-anchored+MMPs+with+therapeutic+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies</span></div><div class="casAuthors">Devy Laetitia; Dransfield Daniel T</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry research international</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191670</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MMP intervention strategies have met with limited clinical success due to severe toxicities.  In particular, treatment with broad-spectrum MMP-inhibitors (MMPIs) caused musculoskeletal pain and inflammation.  Selectivity may be essential for realizing the clinical potential of MMPIs.  Here we review discoveries pinpointing membrane-bound MMPs as mediators of mechanisms underlying cancer and inflammation and as possible therapeutic targets for prevention/treatment of these diseases.  We discuss strategies to target these therapeutic proteases using highly selective inhibitory agents (i.e., human blocking antibodies) against individual membrane-bound MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDe2cVRPsAcYhLSh9fo81bfW6udTcc2ebaCScFn5oBL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1GgsQ%253D%253D&md5=af13351ed768e100fc35dd2df5e51b7e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevy%26aufirst%3DL.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26atitle%3DNew%2520strategies%2520for%2520the%2520next%2520generation%2520of%2520matrix-metalloproteinase%2520inhibitors%253A%2520selectively%2520targeting%2520membrane-anchored%2520MMPs%2520with%2520therapeutic%2520antibodies%26jtitle%3DBiochem.%2520Res.%2520Int.%26date%3D2011%26volume%3D2011%26spage%3D191670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleifeld, O.</span><span> </span><span class="NLM_article-title">Tumour microenvironment—opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&author=C.+M.+Overallauthor=O.+Kleifeld&title=Tumour+microenvironment%E2%80%94opinion%3A+validating+matrix+metalloproteinases+as+drug+targets+and+anti-targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lh9Rxth0LXVxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTumour%2520microenvironment%25E2%2580%2594opinion%253A%2520validating%2520matrix%2520metalloproteinases%2520as%2520drug%2520targets%2520and%2520anti-targets%2520for%2520cancer%2520therapy%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D227%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Talvensaari-Mattila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paakko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyhtya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Sequeiros, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpeenniemi-Hujanen, T.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=1153-1162&author=A.+Talvensaari-Mattilaauthor=P.+Paakkoauthor=M.+Hoyhtyaauthor=G.+Blanco-Sequeirosauthor=T.+Turpeenniemi-Hujanen&title=Matrix+metalloproteinase-2+immunoreactive+protein%3A+a+marker+of+aggressiveness+in+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalvensaari-Mattila%26aufirst%3DA.%26aulast%3DPaakko%26aufirst%3DP.%26aulast%3DHoyhtya%26aufirst%3DM.%26aulast%3DBlanco-Sequeiros%26aufirst%3DG.%26aulast%3DTurpeenniemi-Hujanen%26aufirst%3DT.%26atitle%3DMatrix%2520metalloproteinase-2%2520immunoreactive%2520protein%253A%2520a%2520marker%2520of%2520aggressiveness%2520in%2520breast%2520carcinoma%26jtitle%3DCancer%26date%3D1998%26volume%3D83%26spage%3D1153%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Still, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autzen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdy, F. C.</span><span> </span><span class="NLM_article-title">Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2000&pages=18-25&author=K.+Stillauthor=C.+N.+Robsonauthor=P.+Autzenauthor=M.+C.+Robinsonauthor=F.+C.+Hamdy&title=Localization+and+quantification+of+mRNA+for+matrix+metalloproteinase-2+%28MMP-2%29+and+tissue+inhibitor+of+matrix+metalloproteinase-2+%28TIMP-2%29+in+human+benign+and+malignant+prostatic+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DK.%26aulast%3DRobson%26aufirst%3DC.%2BN.%26aulast%3DAutzen%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DM.%2BC.%26aulast%3DHamdy%26aufirst%3DF.%2BC.%26atitle%3DLocalization%2520and%2520quantification%2520of%2520mRNA%2520for%2520matrix%2520metalloproteinase-2%2520%2528MMP-2%2529%2520and%2520tissue%2520inhibitor%2520of%2520matrix%2520metalloproteinase-2%2520%2528TIMP-2%2529%2520in%2520human%2520benign%2520and%2520malignant%2520prostatic%2520tissue%26jtitle%3DProstate%26date%3D2000%26volume%3D42%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Koshiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosotani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, M.</span><span> </span><span class="NLM_article-title">Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1998&pages=642-650&author=T.+Koshibaauthor=R.+Hosotaniauthor=M.+Wadaauthor=Y.+Miyamotoauthor=K.+Fujimotoauthor=J.+U.+Leeauthor=R.+Doiauthor=S.+Ariiauthor=M.+Imamura&title=Involvement+of+matrix+metalloproteinase-2+activity+in+invasion+and+metastasis+of+pancreatic+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoshiba%26aufirst%3DT.%26aulast%3DHosotani%26aufirst%3DR.%26aulast%3DWada%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BU.%26aulast%3DDoi%26aufirst%3DR.%26aulast%3DArii%26aufirst%3DS.%26aulast%3DImamura%26aufirst%3DM.%26atitle%3DInvolvement%2520of%2520matrix%2520metalloproteinase-2%2520activity%2520in%2520invasion%2520and%2520metastasis%2520of%2520pancreatic%2520carcinoma%26jtitle%3DCancer%26date%3D1998%26volume%3D82%26spage%3D642%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Nomura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span> </span><span class="NLM_article-title">Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1002%2F%28SICI%291097-0215%2819960220%2969%3A1%3C9%3A%3AAID-IJC3%3E3.0.CO%3B2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=8600068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADyaK28Xit1yntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1996&pages=9-16&author=H.+Nomuraauthor=N.+Fujimotoauthor=M.+Seikiauthor=M.+Maiauthor=Y.+Okada&title=Enhanced+production+of+matrix+metalloproteinases+and+activation+of+matrix+metalloproteinase+2+%28gelatinase+A%29+in+human+gastric+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas</span></div><div class="casAuthors">Nomura, Hidehiro; Fujimoto, Noboru; Seiki, Motoharu; Mai, Masayoshi; Okada, Yasunori</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">The authors examd. the prodn. and tissue localization of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in gastric carcinoma tissues.  MMP-1 (tissue collagenase), MMP-9 (gelatinase B) and TIMP-2 were immunolocalized in carcinoma cells and MMP-2 (gelatinase A) on tumor cell membranes, whereas no or little immunostaining for MMP-3 (stromelysin-1) and TIMP-1 was seen in carcinoma cells.  Stromal cells in carcinoma tissue were also pos. stained for these MMPs and TIMPs.  MMP-2 immunostaining was obsd. exclusively on advanced gastric carcinoma cells and correlated with vascular invasion by tumor cells.  Sandwich enzyme immunoassays revealed enhanced prodn. of MMP-1, MMP-2, MMP-3, MMP-9 and TIMP-1 by carcinoma tissues.  Gelatinolytic activities were higher in carcinoma samples than in normal controls.  Using gelatin zymog., active forms of MMP-2 and MMP-9 were more frequently detected in carcinoma tissue, and the activation rate of the zymogen of MMP-2 (proMMP-2), but not that of proMMP-9, correlated well with degree of local invasion and lymphatic permeation.  The data indicate an enhanced prodn. of 4 MMPs in gastric carcinoma tissue and suggest that activation of pro-MMP-2 may be a key step for spreading of gastric carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHyxUZ34uyrbVg90H21EOLACvtfcHk0li449RUw7RkBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit1yntr8%253D&md5=50fb4fe51a46aef25117f60fe0fde311</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819960220%2969%3A1%3C9%3A%3AAID-IJC3%3E3.0.CO%3B2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819960220%252969%253A1%253C9%253A%253AAID-IJC3%253E3.0.CO%253B2-8%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DH.%26aulast%3DFujimoto%26aufirst%3DN.%26aulast%3DSeiki%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26atitle%3DEnhanced%2520production%2520of%2520matrix%2520metalloproteinases%2520and%2520activation%2520of%2520matrix%2520metalloproteinase%25202%2520%2528gelatinase%2520A%2529%2520in%2520human%2520gastric%2520carcinomas%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1996%26volume%3D69%26spage%3D9%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rojiani, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alidina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojiani, A. M.</span><span> </span><span class="NLM_article-title">Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FktFyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=775-781&author=M.+V.+Rojianiauthor=J.+Alidinaauthor=N.+Espositoauthor=A.+M.+Rojiani&title=Expression+of+MMP-2+correlates+with+increased+angiogenesis+in+CNS+metastasis+of+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma</span></div><div class="casAuthors">Rojiani Mumtaz V; Alidina Janeen; Esposito Nicole; Rojiani Amyn M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">775-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMP) have been implicated in increased invasive and metastatic potential of tumors, possibly via interactions with the extracellular matrix and angiogenesis.  This study investigates the relationship between MMP-2 immunoexpression and angiogenesis in a series of lung carcinomas metastatic to the central nervous system (CNS).  Twenty eight metastatic carcinoma cases with adequate brain-tumor interface were identified from the archives at the Moffitt Cancer Center.  MMP-2 expression was determined by immunohistochemistry using an antibody directed against pro and active forms (NeoMarkers).  Similarly, microvessels were identified on parallel sections with anti-CD34 antibody (Biogenix).  Angiogenesis profiles within the tumor and at the CNS/tumor interface were morphometrically assessed by the Image Pro Plus image analysis system.  Briefly, CD34 positive vessels were quantitated and correlated with presence or absence of MMP-2 expression in the tumor.  Mean microvessel area (MMVA) and mean microvessel number (MMVN) were assessed within areas of brain-tumor interface and within the tumor and expressed as a ratio relative to the tumor.  Sixteen (57.14%) metastatic tumors were strongly immunoreac-tive for MMP-2, while 12 (42.86%) were negative.  MMP-2 positive tumors had a higher MMVA and MMVN ratio at the CNS/tumor interface in comparison to MMP-2 negative neoplasms.  MMP-2 expression thus appears to confer enhanced vascular proliferation particularly at the brain-tumor interface which would support the contention of enhanced capability of growth and invasion within the CNS, possibly modulated by MMP2.  The relationship between MMP-2 expression and angiogenesis has been previously reported and its biological and therapeutic implications remain the focus of investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTfWNW_HPIT7Z0d-O_J5C0AfW6udTcc2eZlkDjt44meu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FktFyqtA%253D%253D&md5=5df31e2962f61f3a2659a3d3a4b8322d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRojiani%26aufirst%3DM.%2BV.%26aulast%3DAlidina%26aufirst%3DJ.%26aulast%3DEsposito%26aufirst%3DN.%26aulast%3DRojiani%26aufirst%3DA.%2BM.%26atitle%3DExpression%2520of%2520MMP-2%2520correlates%2520with%2520increased%2520angiogenesis%2520in%2520CNS%2520metastasis%2520of%2520lung%2520carcinoma%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardo, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotra, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Potent and selective mechanism-based inhibition of gelatinases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">6799</span><span class="NLM_x">–</span> <span class="NLM_lpage">6800</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja001461n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=6799-6800&author=S.+Brownauthor=M.+M.+Bernardoauthor=Z.+H.+Liauthor=L.+P.+Kotraauthor=Y.+Tanakaauthor=R.+Fridmanauthor=S.+Mobashery&title=Potent+and+selective+mechanism-based+inhibition+of+gelatinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja001461n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001461n%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520mechanism-based%2520inhibition%2520of%2520gelatinases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D6799%26epage%3D6800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Forbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llarrull, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossing, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1111%2Fj.1747-0285.2009.00881.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=19807733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=527-534&author=C.+Forbesauthor=Q.+Shiauthor=J.+F.+Fisherauthor=M.+Leeauthor=D.+Hesekauthor=L.+I.+Llarrullauthor=M.+Tothauthor=M.+Gossingauthor=R.+Fridmanauthor=S.+Mobashery&title=Active+site+ring-opening+of+a+thiirane+moiety+and+picomolar+inhibition+of+gelatinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases</span></div><div class="casAuthors">Forbes, Christopher; Shi, Qicun; Fisher, Jed F.; Lee, Mijoon; Hesek, Dusan; Llarrull, Leticia I.; Toth, Marta; Gossing, Michael; Fridman, Rafael; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">527-534</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">(±)-2-[(4-Phenoxyphenylsulfonyl)methyl]thiirane (1) is a potent and selective mechanism-based inhibitor of the gelatinase sub-class of the zinc-dependent matrix metalloproteinase family.  Inhibitor 1 has excellent activity in in vivo models of gelatinase-dependent disease.  We demonstrate that the mechanism of inhibition is a rate-limiting gelatinase-catalyzed thiolate generation via deprotonation adjacent to the thiirane, with concomitant thiirane opening.  A corollary to this mechanism is the prediction that thiol-contg. structures, related to thiirane-opened 1, will possess potent matrix metalloproteinase inhibitory activity.  This prediction was validated by the synthesis of the product of this enzyme-catalyzed reaction on 1, which exhibited a remarkable Ki of 530 pM against matrix metalloproteinase-2.  Thiirane 1 acts as a caged thiol, unmasked selectively in the active sites of gelatinases.  This mechanism is unprecedented in the substantial literature on inhibition of zinc-dependent hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4TF4L9ayFLVg90H21EOLACvtfcHk0li3m05RS40ojg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7nF&md5=11ec87b9c4ddd1627d67bf5fb4e43362</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00881.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00881.x%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DGossing%26aufirst%3DM.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DActive%2520site%2520ring-opening%2520of%2520a%2520thiirane%2520moiety%2520and%2520picomolar%2520inhibition%2520of%2520gelatinases%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D527%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas-Estrada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celenza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreitinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Metabolism of a highly selective gelatinase inhibitor generates active metabolite</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1111%2Fj.1747-0285.2007.00577.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=17927722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlart7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=371-382&author=M.+Leeauthor=A.+Villegas-Estradaauthor=G.+Celenzaauthor=B.+Boggessauthor=M.+Tothauthor=G.+Kreitingerauthor=C.+Forbesauthor=R.+Fridmanauthor=S.+Mobasheryauthor=M.+Chang&title=Metabolism+of+a+highly+selective+gelatinase+inhibitor+generates+active+metabolite"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of a highly selective gelatinase inhibitor generates active metabolite</span></div><div class="casAuthors">Lee, Mijoon; Villegas-Estrada, Adriel; Celenza, Giuseppe; Boggess, Bill; Toth, Marta; Kreitinger, Gloria; Forbes, Christopher; Fridman, Rafael; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">371-382</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">(4-Phenoxyphenylsulfonyl)methylthiirane (inhibitor 1) is a highly selective inhibitor of gelatinases (matrix metalloproteinases 2 and 9), which is showing considerable promise in animal models for cancer and stroke.  Despite demonstrated potent, selective, and effective inhibition of gelatinases both in vitro and in vivo, the compd. is rapidly metabolized, implying that the likely activity in vivo is due to a metabolite rather than the compd. itself.  To this end, metab. of inhibitor 1 was investigated in in vitro systems.  Four metabolites were identified by LC/MS-MS and the structures of three of them were further validated by comparison with authentic synthetic samples.  One metabolite, 4-(4-thiiranylmethanesulfonylphenoxy)phenol (I), was generated by hydroxylation of the terminal Ph group of 1.  This compd. was investigated in kinetics of inhibition of several matrix metalloproteinases.  This metabolite was a more potent slow-binding inhibitor of gelatinases (matrix metalloproteinase-2 and matrix metalloproteinase-9) than the parent compd. 1, but it also served as a slow-binding inhibitor of matrix metalloproteinase-14, the upstream activator of matrix metalloproteinase-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSVma4hIKVwrVg90H21EOLACvtfcHk0liwW_28VIW-wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlart7%252FN&md5=c4bda3a0e7559417a5932837d779797c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00577.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00577.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%26aulast%3DVillegas-Estrada%26aufirst%3DA.%26aulast%3DCelenza%26aufirst%3DG.%26aulast%3DBoggess%26aufirst%3DB.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DKreitinger%26aufirst%3DG.%26aulast%3DForbes%26aufirst%3DC.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DMetabolism%2520of%2520a%2520highly%2520selective%2520gelatinase%2520inhibitor%2520generates%2520active%2520metabolite%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D371%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gooyit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikejiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckow, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Selective water-soluble gelatinase inhibitor prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6676</span><span class="NLM_x">–</span> <span class="NLM_lpage">6690</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200566e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6676-6690&author=M.+Gooyitauthor=M.+Leeauthor=V.+A.+Schroederauthor=M.+Ikejiriauthor=M.+A.+Suckowauthor=S.+Mobasheryauthor=M.+Chang&title=Selective+water-soluble+gelatinase+inhibitor+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm200566e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200566e%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSchroeder%26aufirst%3DV.%2BA.%26aulast%3DIkejiri%26aufirst%3DM.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSelective%2520water-soluble%2520gelatinase%2520inhibitor%2520prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6676%26epage%3D6690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Bonfil, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trindade Filho, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osenkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinni, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vessella, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cher, M. L.</span><span> </span><span class="NLM_article-title">Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.2353%2Fajpath.2007.060720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2007&pages=2100-2111&author=R.+D.+Bonfilauthor=Z.+Dongauthor=J.+C.+Trindade+Filhoauthor=A.+Sabbotaauthor=P.+Osenkowskiauthor=S.+Nabhaauthor=H.+Yamamotoauthor=S.+R.+Chinniauthor=H.+Zhaoauthor=S.+Mobasheryauthor=R.+L.+Vessellaauthor=R.+Fridmanauthor=M.+L.+Cher&title=Prostate+cancer-associated+membrane+type+1-matrix+metalloproteinase%3A+a+pivotal+role+in+bone+response+and+intraosseous+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth</span></div><div class="casAuthors">Bonfil, R. Daniel; Dong, Zhong; Carlos, J.; Filho, Trindade; Sabbota, Aaron; Osenkowski, Pamela; Nabha, Sanaa; Yamamoto, Hamilto; Chinni, Sreenivasa R.; Zhao, Huiren; Mobashery, Shahriar; Vessella, Robert L.; Fridman, Rafael; Cher, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2100-2111</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Membrane type 1-matrix metalloproteinase (MT1-MMP) is a major mediator of collagen I degrdn.  In human samples, we show that prostate cancer cells in skeletal metastases consistently express abundant MT1-MMP protein.  Because prostate cancer bone metastasis requires remodeling of the collagen-rich bone matrix, we investigated the role of cancer cell-derived MT1-MMP in an exptl. model of tumor-bone interaction.  MT1-MMP-deficient LNCaP human prostate cancer cells were stably transfected with human wild-type MT1-MMP (MT1wt).  Furthermore, endogenous MT1-MMP was down-regulated by small interfering RNA in DU145 human prostate cancer cells.  Intratibial tumor injection in severe combined immunodeficient mice was used to simulate intraosseous growth of metastatic tumors.  LNCaP-MT1wt cells produced larger osseous tumors than Neo control cells and induced osteolysis, whereas DU145 MT1-MMP-silenced transfectants induced osteogenic changes.  In vitro assays showed that MT1wt overexpression enhanced collagen I degrdn., whereas MT1-MMP-silencing did the opposite, suggesting that tumor-derived MT1-MMP may contribute directly to bone remodeling.  LNCaP-MT1wt-derived conditioned medium stimulated in vitro multinucleated osteoclast formation.  This effect was inhibited by osteoprotegerin, a decoy receptor for receptor activator of nuclear factor κB ligand, and by 4-[4-(methanesulfonamido) phenoxy] phenylsulfonyl methylthiirane, an MT1-MMP inhibitor.  Our findings are consistent with the hypothesis that prostate cancer-assocd. MT1-MMP plays a direct and/or indirect role in bone matrix degrdn., thus favoring intraosseous tumor expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQE2LrT2SA3rVg90H21EOLACvtfcHk0ljda0VD_6QapQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlOhtbo%253D&md5=365fdb4af6479ebe715cc441456cc62b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2007.060720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2007.060720%26sid%3Dliteratum%253Aachs%26aulast%3DBonfil%26aufirst%3DR.%2BD.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DTrindade%2BFilho%26aufirst%3DJ.%2BC.%26aulast%3DSabbota%26aufirst%3DA.%26aulast%3DOsenkowski%26aufirst%3DP.%26aulast%3DNabha%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DChinni%26aufirst%3DS.%2BR.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DVessella%26aufirst%3DR.%2BL.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DCher%26aufirst%3DM.%2BL.%26atitle%3DProstate%2520cancer-associated%2520membrane%2520type%25201-matrix%2520metalloproteinase%253A%2520a%2520pivotal%2520role%2520in%2520bone%2520response%2520and%2520intraosseous%2520tumor%2520growth%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2007%26volume%3D170%26spage%3D2100%26epage%3D2111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikejiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimpel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espahbodi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumarasiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noll, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Structure–activity relationship for thiirane-based gelatinase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300050b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=490-495&author=M.+Leeauthor=M.+Ikejiriauthor=D.+Klimpelauthor=M.+Tothauthor=M.+Espahbodiauthor=D.+Hesekauthor=C.+Forbesauthor=M.+Kumarasiriauthor=B.+C.+Nollauthor=M.+Changauthor=S.+Mobashery&title=Structure%E2%80%93activity+relationship+for+thiirane-based+gelatinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300050b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300050b%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%26aulast%3DIkejiri%26aufirst%3DM.%26aulast%3DKlimpel%26aufirst%3DD.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DEspahbodi%26aufirst%3DM.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DForbes%26aufirst%3DC.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DNoll%26aufirst%3DB.%2BC.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520for%2520thiirane-based%2520gelatinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D490%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Minkkila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myllymaki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo-Melendez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koskinen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span> </span><span class="NLM_article-title">The synthesis and biological evaluation of para-substituted phenolic <i>N</i>-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2994-3008&author=A.+Minkkilaauthor=M.+J.+Myllymakiauthor=S.+M.+Saarioauthor=J.+A.+Castillo-Melendezauthor=A.+M.+Koskinenauthor=C.+J.+Fowlerauthor=J.+Leppanenauthor=T.+Nevalainen&title=The+synthesis+and+biological+evaluation+of+para-substituted+phenolic+N-alkyl+carbamates+as+endocannabinoid+hydrolyzing+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinkkila%26aufirst%3DA.%26aulast%3DMyllymaki%26aufirst%3DM.%2BJ.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DCastillo-Melendez%26aufirst%3DJ.%2BA.%26aulast%3DKoskinen%26aufirst%3DA.%2BM.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DLeppanen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520para-substituted%2520phenolic%2520N-alkyl%2520carbamates%2520as%2520endocannabinoid%2520hydrolyzing%2520enzyme%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mayer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedecoq, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidaluc, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbert, T.</span><span> </span><span class="NLM_article-title">New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3653</span><span class="NLM_x">–</span> <span class="NLM_lpage">3664</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm991121g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3653-3664&author=P.+Mayerauthor=P.+Brunelauthor=C.+Chaplainauthor=C.+Piedecoqauthor=F.+Calmelauthor=P.+Schambelauthor=P.+Chopinauthor=T.+Wurchauthor=P.+J.+Pauwelsauthor=M.+Marienauthor=J.+L.+Vidalucauthor=T.+Imbert&title=New+substituted+1-%282%2C3-dihydrobenzo%5B1%2C4%5Ddioxin-2-ylmethyl%29piperidin-4-yl+derivatives+with+alpha%282%29-adrenoceptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm991121g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991121g%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DBrunel%26aufirst%3DP.%26aulast%3DChaplain%26aufirst%3DC.%26aulast%3DPiedecoq%26aufirst%3DC.%26aulast%3DCalmel%26aufirst%3DF.%26aulast%3DSchambel%26aufirst%3DP.%26aulast%3DChopin%26aufirst%3DP.%26aulast%3DWurch%26aufirst%3DT.%26aulast%3DPauwels%26aufirst%3DP.%2BJ.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DVidaluc%26aufirst%3DJ.%2BL.%26aulast%3DImbert%26aufirst%3DT.%26atitle%3DNew%2520substituted%25201-%25282%252C3-dihydrobenzo%255B1%252C4%255Ddioxin-2-ylmethyl%2529piperidin-4-yl%2520derivatives%2520with%2520alpha%25282%2529-adrenoceptor%2520antagonist%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3653%26epage%3D3664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Pochetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gege, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taveras, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazza, F.</span><span> </span><span class="NLM_article-title">Extra binding region induced by non-zinc chelating inhibitors into the S1′ subsite of matrix metalloproteinase 8 (MMP-8)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801166j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1040-1049&author=G.+Pochettiauthor=R.+Montanariauthor=C.+Gegeauthor=C.+Chevrierauthor=A.+G.+Taverasauthor=F.+Mazza&title=Extra+binding+region+induced+by+non-zinc+chelating+inhibitors+into+the+S1%E2%80%B2+subsite+of+matrix+metalloproteinase+8+%28MMP-8%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm801166j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801166j%26sid%3Dliteratum%253Aachs%26aulast%3DPochetti%26aufirst%3DG.%26aulast%3DMontanari%26aufirst%3DR.%26aulast%3DGege%26aufirst%3DC.%26aulast%3DChevrier%26aufirst%3DC.%26aulast%3DTaveras%26aufirst%3DA.%2BG.%26aulast%3DMazza%26aufirst%3DF.%26atitle%3DExtra%2520binding%2520region%2520induced%2520by%2520non-zinc%2520chelating%2520inhibitors%2520into%2520the%2520S1%25E2%2580%25B2%2520subsite%2520of%2520matrix%2520metalloproteinase%25208%2520%2528MMP-8%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1040%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Gooyit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1111%2Fj.1747-0285.2009.00898.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=19824893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=535-546&author=M.+Gooyitauthor=M.+Leeauthor=D.+Hesekauthor=B.+Boggessauthor=A.+G.+Oliverauthor=R.+Fridmanauthor=S.+Mobasheryauthor=M.+Chang&title=Synthesis%2C+kinetic+characterization+and+metabolism+of+diastereomeric+2-%281-%284-phenoxyphenylsulfonyl%29ethyl%29thiiranes+as+potent+gelatinase+and+MT1-MMP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors</span></div><div class="casAuthors">Gooyit, Major; Lee, Mijoon; Hesek, Dusan; Boggess, Bill; Oliver, Allen G.; Fridman, Rafael; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">535-546</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gelatinases (MMP-2 and MMP-9) have been implicated in a no. of pathol. conditions, including cancer and cardiovascular disease.  Hence, small mol. inhibitors of these enzymes are highly sought for use as potential therapeutic agents.  2-(4-Phenoxyphenylsulfonylmethyl)thiirane (SB-3CT) has previously been demonstrated to be a potent and selective inhibitor of gelatinases, however, it is rapidly metabolized because of oxidn. at the para position of the phenoxy ring and at the α-position to the sulfonyl group.  α-Me variants of SB-3CT were conceived to improve metabolic stability and as mechanistic probes.  We describe herein the synthesis and evaluation of these structural variants as potent inhibitors of gelatinases.  Two (compds. 5b and 5d) among the four synthetic stereoisomers were found to exhibit slow-binding inhibition of gelatinases and MMP-14 (MT1-MMP), which is a hallmark of the mechanism of this class of inhibitors.  The ability of these compds. to inhibit MMP-2, MMP-9, and MMP-14 could target cancer tissues more effectively.  Metab. of the newly synthesized inhibitors showed that both oxidn. at the α-position to the sulfonyl group and oxidn. at the para position of the terminal Ph ring were prevented.  Instead oxidn. on the thiirane sulfur is the only biotransformation pathway obsd. for these gelatinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxkzohVUsbXrVg90H21EOLACvtfcHk0lghfqnH8-azog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7bM&md5=53d801a92815933fe7f578d34c1f926e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00898.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00898.x%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DBoggess%26aufirst%3DB.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520kinetic%2520characterization%2520and%2520metabolism%2520of%2520diastereomeric%25202-%25281-%25284-phenoxyphenylsulfonyl%2529ethyl%2529thiiranes%2520as%2520potent%2520gelatinase%2520and%2520MT1-MMP%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D535%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Gooyit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckow, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Selective gelatinase inhibitor neuroprotective agents cross the blood–brain barrier</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300062w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=730-736&author=M.+Gooyitauthor=M.+A.+Suckowauthor=K.+L.+Schroederauthor=W.+R.+Wolterauthor=S.+Mobasheryauthor=M.+Chang&title=Selective+gelatinase+inhibitor+neuroprotective+agents+cross+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Gooyit, Major; Suckow, Mark A.; Schroeder, Valerie A.; Wolter, William R.; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">730-736</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SB-3CT, a potent and selective inhibitor of matrix metalloproteinase-2 and -9, has shown efficacy in several animal models of neurol. diseases.  One of the greatest challenges in the development of therapeutics for neurol. diseases is the inability of drugs to cross the blood-brain barrier.  A sensitive bioanal. method based on ultraperformance liq. chromatog. with multiple-reaction monitoring detection was developed to measure levels of SB-3CT, its active metabolite, the α-Me analog, and its p-hydroxy metabolite in plasma and brain.  The compds. are rapidly absorbed and are readily distributed to the brain.  The pharmacokinetic properties of these gelatinase inhibitors and the efficacy shown by SB-3CT in animal models of stroke, subarachnoid hemorrhage, and spinal cord injury indicate that this class of compds. holds considerable promise in the treatment of diseases of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmol4U6a2bIbVg90H21EOLACvtfcHk0lhbDBuHh7hM8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE&md5=05f147cd30e827b2d81b155af8a6c418</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn300062w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300062w%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DK.%2BL.%26aulast%3DWolter%26aufirst%3DW.%2BR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSelective%2520gelatinase%2520inhibitor%2520neuroprotective%2520agents%2520cross%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D730%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ikejiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardo, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfil, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Potent mechanism-based inhibitors for matrix metalloproteinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">33992</span><span class="NLM_x">–</span> <span class="NLM_lpage">34002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=33992-34002&author=M.+Ikejiriauthor=M.+M.+Bernardoauthor=R.+D.+Bonfilauthor=M.+Tothauthor=M.+Changauthor=R.+Fridmanauthor=S.+Mobashery&title=Potent+mechanism-based+inhibitors+for+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkejiri%26aufirst%3DM.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DBonfil%26aufirst%3DR.%2BD.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DPotent%2520mechanism-based%2520inhibitors%2520for%2520matrix%2520metalloproteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D33992%26epage%3D34002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, H. B.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1030</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1030-1037&author=P.+Taoauthor=J.+F.+Fisherauthor=Q.+Shiauthor=S.+Mobasheryauthor=H.+B.+Schlegel&title=Matrix+metalloproteinase+2+%28MMP2%29+inhibition%3A+DFT+and+QM%2FMM+studies+of+the+deprotonation-initialized+ring-opening+reaction+of+the+sulfoxide+analogue+of+SB-3CT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DP.%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DSchlegel%26aufirst%3DH.%2BB.%26atitle%3DMatrix%2520metalloproteinase%25202%2520%2528MMP2%2529%2520inhibition%253A%2520DFT%2520and%2520QM%252FMM%2520studies%2520of%2520the%2520deprotonation-initialized%2520ring-opening%2520reaction%2520of%2520the%2520sulfoxide%2520analogue%2520of%2520SB-3CT%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2009%26volume%3D114%26spage%3D1030%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lio8kQLuQlhUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Charles Edwin Raja Gabriel, Trung T. Nguyen, Emanuele Marco Gargano, Jed F. Fisher, Mayland Chang, <span class="NLM_string-name hlFld-ContribAuthor">Shahriar Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (3)
                                     , 1204-1213. <a href="https://doi.org/10.1021/acsptsci.1c00063" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00063%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DMetabolism%252Bof%252Bthe%252BSelective%252BMatrix%252BMetalloproteinase-9%252BInhibitor%252B%252528R%252529-ND-336%26aulast%3DGabriel%26aufirst%3DCharles%2BEdwin%2BRaja%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25022021%26date%3D06042021%26volume%3D4%26issue%3D3%26spage%3D1204%26epage%3D1213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mayland Chang, <span class="NLM_string-name hlFld-ContribAuthor">Trung T. Nguyen</span>. </span><span class="cited-content_cbyCitation_article-title">Strategy for Treatment of Infected Diabetic Foot Ulcers. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (5)
                                     , 1080-1093. <a href="https://doi.org/10.1021/acs.accounts.0c00864" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00864%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DStrategy%252Bfor%252BTreatment%252Bof%252BInfected%252BDiabetic%252BFoot%252BUlcers%26aulast%3DChang%26aufirst%3DMayland%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21122020%26date%3D17022021%26volume%3D54%26issue%3D5%26spage%3D1080%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pauline Zipfel, Christophe Rochais, Kévin Baranger, Santiago Rivera, <span class="NLM_string-name hlFld-ContribAuthor">Patrick Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10705-10725. <a href="https://doi.org/10.1021/acs.jmedchem.0c00352" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00352%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMatrix%252BMetalloproteinases%252Bas%252BNew%252BTargets%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BOpportunities%252Band%252BChallenges%26aulast%3DZipfel%26aufirst%3DPauline%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D19%26spage%3D10705%26epage%3D10725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Chen, Hao Xiong, Jing-Fang Yang, Xiao-Lei Zhu, Ren-Yu Qu, <span class="NLM_string-name hlFld-ContribAuthor">Guang-Fu Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Diaryl Ether: A Privileged Scaffold for Drug and Agrochemical Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2020,</strong> <em>68 </em>
                                    (37)
                                     , 9839-9877. <a href="https://doi.org/10.1021/acs.jafc.0c03369" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c03369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c03369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c03369%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDiaryl%252BEther%25253A%252BA%252BPrivileged%252BScaffold%252Bfor%252BDrug%252Band%252BAgrochemical%252BDiscovery%26aulast%3DChen%26aufirst%3DTao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27052020%26date%3D11082020%26date%3D11082020%26date%3D29082020%26date%3D11082020%26volume%3D68%26issue%3D37%26spage%3D9839%26epage%3D9877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Trung T. Nguyen, William R. Wolter, Bowen Anderson, Valerie A. Schroeder, Ming Gao, Major Gooyit, Mark A. Suckow, <span class="NLM_string-name hlFld-ContribAuthor">Mayland Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Limitations of Knockout Mice and Other Tools in Assessment of the Involvement of Matrix Metalloproteinases in Wound Healing and the Means to Overcome Them. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (3)
                                     , 489-495. <a href="https://doi.org/10.1021/acsptsci.9b00109" title="DOI URL">https://doi.org/10.1021/acsptsci.9b00109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.9b00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.9b00109%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DLimitations%252Bof%252BKnockout%252BMice%252Band%252BOther%252BTools%252Bin%252BAssessment%252Bof%252Bthe%252BInvolvement%252Bof%252BMatrix%252BMetalloproteinases%252Bin%252BWound%252BHealing%252Band%252Bthe%252BMeans%252Bto%252BOvercome%252BThem%26aulast%3DNguyen%26aufirst%3DTrung%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D02122019%26date%3D03032020%26date%3D24022020%26volume%3D3%26issue%3D3%26spage%3D489%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bernd Beutel, Jian Song, Christian Paul Konken, Eva Korpos, Benjamin Schinor, Hanna Gerwien, Reshma Vidyadharan, Miriam Burmeister, Lixia Li, Günter Haufe, <span class="NLM_string-name hlFld-ContribAuthor">Lydia Sorokin</span>. </span><span class="cited-content_cbyCitation_article-title">New in Vivo Compatible Matrix Metalloproteinase  (MMP)-2 and MMP-9 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2018,</strong> <em>29 </em>
                                    (11)
                                     , 3715-3725. <a href="https://doi.org/10.1021/acs.bioconjchem.8b00618" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.8b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.8b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.8b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DNew%252Bin%252BVivo%252BCompatible%252BMatrix%252BMetalloproteinase%252B%252528MMP%252529-2%252Band%252BMMP-9%252BInhibitors%26aulast%3DBeutel%26aufirst%3DBernd%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30082018%26date%3D01102018%26date%3D24102018%26date%3D02102018%26volume%3D29%26issue%3D11%26spage%3D3715%26epage%3D3725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Trung T. Nguyen, Derong Ding, William R. Wolter, Rocio L. Pérez, Matthew M. Champion, Kiran V. Mahasenan, Dusan Hesek, Mijoon Lee, Valerie A. Schroeder, Jeffrey I. Jones, Elena Lastochkin, Margaret K. Rose, Charles E. Peterson, Mark A. Suckow, Shahriar Mobashery, <span class="NLM_string-name hlFld-ContribAuthor">Mayland Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8825-8837. <a href="https://doi.org/10.1021/acs.jmedchem.8b01005" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DValidation%252Bof%252BMatrix%252BMetalloproteinase-9%252B%252528MMP-9%252529%252Bas%252Ba%252BNovel%252BTarget%252Bfor%252BTreatment%252Bof%252BDiabetic%252BFoot%252BUlcers%252Bin%252BHumans%252Band%252BDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BSmall-Molecule%252BMMP-9%252BInhibitor%252BThat%252BAccelerates%252BHealing%26aulast%3DNguyen%26aufirst%3DTrung%2BT.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25062018%26date%3D27092018%26date%3D13092018%26volume%3D61%26issue%3D19%26spage%3D8825%26epage%3D8837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kiran
V. Mahasenan, Derong Ding, Ming Gao, Trung T. Nguyen, Mark A. Suckow, Valerie A. Schroeder, William R. Wolter, Mayland Chang, <span class="NLM_string-name hlFld-ContribAuthor">Shahriar Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">In Search of Selectivity in Inhibition of ADAM10. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 708-713. <a href="https://doi.org/10.1021/acsmedchemlett.8b00163" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00163%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIn%252BSearch%252Bof%252BSelectivity%252Bin%252BInhibition%252Bof%252BADAM10%26aulast%3DMahasenan%26aufirst%3DKiran%2BV.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08042018%26date%3D11062018%26date%3D13062018%26date%3D11062018%26volume%3D9%26issue%3D7%26spage%3D708%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran V.  Mahasenan</span>, <span class="hlFld-ContribAuthor ">Maria  Bastian</span>, <span class="hlFld-ContribAuthor ">Ming  Gao</span>, <span class="hlFld-ContribAuthor ">Emma  Frost</span>, <span class="hlFld-ContribAuthor ">Derong  Ding</span>, <span class="hlFld-ContribAuthor ">Katerina  Zorina-Lichtenwalter</span>, <span class="hlFld-ContribAuthor ">John  Jacobs</span>, <span class="hlFld-ContribAuthor ">Mark A.  Suckow</span>, <span class="hlFld-ContribAuthor ">Valerie A.  Schroeder</span>, <span class="hlFld-ContribAuthor ">William R.  Wolter</span>, <span class="hlFld-ContribAuthor ">Mayland  Chang</span>, and <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploitation of Conformational Dynamics in Imparting Selective Inhibition for Related Matrix Metalloproteinases. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 654-659. <a href="https://doi.org/10.1021/acsmedchemlett.7b00130" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00130%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DExploitation%252Bof%252BConformational%252BDynamics%252Bin%252BImparting%252BSelective%252BInhibition%252Bfor%252BRelated%252BMatrix%252BMetalloproteinases%26aulast%3DMahasenan%26aufirst%3DKiran%2BV.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23032017%26date%3D01052017%26date%3D03052017%26date%3D08062017%26date%3D01052017%26volume%3D8%26issue%3D6%26spage%3D654%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Gao</span>, <span class="hlFld-ContribAuthor ">Haoqian  Zhang</span>, <span class="hlFld-ContribAuthor ">Alpa  Trivedi</span>, <span class="hlFld-ContribAuthor ">Kiran V.  Mahasenan</span>, <span class="hlFld-ContribAuthor ">Valerie A.  Schroeder</span>, <span class="hlFld-ContribAuthor ">William R.  Wolter</span>, <span class="hlFld-ContribAuthor ">Mark A.  Suckow</span>, <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>, <span class="hlFld-ContribAuthor ">Linda J.  Noble-Haeusslein</span>, and <span class="hlFld-ContribAuthor ">Mayland  Chang</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Inhibition of MMP-2 Does Not Alter Neurological Recovery after Spinal Cord Injury. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (11)
                                     , 1482-1487. <a href="https://doi.org/10.1021/acschemneuro.6b00217" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00217%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSelective%252BInhibition%252Bof%252BMMP-2%252BDoes%252BNot%252BAlter%252BNeurological%252BRecovery%252Bafter%252BSpinal%252BCord%252BInjury%26aulast%3DGao%26aufirst%3DMing%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25072016%26date%3D23082016%26date%3D25082016%26date%3D16112016%26date%3D23082016%26volume%3D7%26issue%3D11%26spage%3D1482%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdelsattar M.  Omar</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, <span class="hlFld-ContribAuthor ">Saleh  Ihmaid</span>, <span class="hlFld-ContribAuthor ">Hany M.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El-Agrody</span>, <span class="hlFld-ContribAuthor ">Ahmed  Mora</span>, <span class="hlFld-ContribAuthor ">Moustafa E.  El-Araby</span>, <span class="hlFld-ContribAuthor ">Hany E.A.  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 103992. <a href="https://doi.org/10.1016/j.bioorg.2020.103992" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103992</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103992%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bmolecular%252Bdiscovery%252Bof%252Bpromising%252Bamidine-based%252Bthiazole%252Banalogues%252Bas%252Bpotent%252Bdual%252BMatrix%252BMetalloproteinase-2%252Band%252B9%252Binhibitors%25253A%252BAnticancer%252Bactivity%252Bdata%252Bwith%252Bprominent%252Bcell%252Bcycle%252Barrest%252Band%252BDNA%252Bfragmentation%252Banalysis%252Beffects%26aulast%3DOmar%26aufirst%3DAbdelsattar%2BM.%26date%3D2020%26volume%3D101%26spage%3D103992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damian  Plażuk</span>, <span class="hlFld-ContribAuthor ">Michał  Łomzik</span>, <span class="hlFld-ContribAuthor ">Karolina  Chrabąszcz</span>, <span class="hlFld-ContribAuthor ">Anna  Wieczorek-Błauż</span>. </span><span class="cited-content_cbyCitation_article-title">Thiiranes and Thiirenes—Monocyclic. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14786-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14786-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14786-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14786-9%26sid%3Dliteratum%253Aachs%26atitle%3DThiiranes%252Band%252BThiirenes%2525E2%252580%252594Monocyclic%26aulast%3DPla%25C5%25BCuk%26aufirst%3DDamian%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleix  Gimeno</span>, <span class="hlFld-ContribAuthor ">Raúl  Beltrán-Debón</span>, <span class="hlFld-ContribAuthor ">Miquel  Mulero</span>, <span class="hlFld-ContribAuthor ">Gerard  Pujadas</span>, <span class="hlFld-ContribAuthor ">Santiago  Garcia-Vallvé</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the variability of the S1′ pocket to improve matrix metalloproteinase inhibitor selectivity profiles. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 38-57. <a href="https://doi.org/10.1016/j.drudis.2019.07.013" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DUnderstanding%252Bthe%252Bvariability%252Bof%252Bthe%252BS1%2525E2%252580%2525B2%252Bpocket%252Bto%252Bimprove%252Bmatrix%252Bmetalloproteinase%252Binhibitor%252Bselectivity%252Bprofiles%26aulast%3DGimeno%26aufirst%3DAleix%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D38%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiawei  Wang</span>, <span class="hlFld-ContribAuthor ">Peng  Qian</span>, <span class="hlFld-ContribAuthor ">Kangfei  Hu</span>, <span class="hlFld-ContribAuthor ">Zhenggen  Zha</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Electrocatalytic Fixation of Carbon Dioxide with Amines and Arylketones. </span><span class="cited-content_cbyCitation_journal-name">ChemElectroChem</span><span> <strong>2019,</strong> <em>6 </em>
                                    (16)
                                     , 4292-4296. <a href="https://doi.org/10.1002/celc.201801724" title="DOI URL">https://doi.org/10.1002/celc.201801724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/celc.201801724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcelc.201801724%26sid%3Dliteratum%253Aachs%26jtitle%3DChemElectroChem%26atitle%3DElectrocatalytic%252BFixation%252Bof%252BCarbon%252BDioxide%252Bwith%252BAmines%252Band%252BArylketones%26aulast%3DWang%26aufirst%3DJiawei%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D16%26spage%3D4292%26epage%3D4296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Fischer</span>, <span class="hlFld-ContribAuthor ">Nicole  Senn</span>, <span class="hlFld-ContribAuthor ">Rainer  Riedl</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Structural Evolution of Matrix Metalloproteinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (34)
                                     , 7960-7980. <a href="https://doi.org/10.1002/chem.201805361" title="DOI URL">https://doi.org/10.1002/chem.201805361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201805361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201805361%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDesign%252Band%252BStructural%252BEvolution%252Bof%252BMatrix%252BMetalloproteinase%252BInhibitors%26aulast%3DFischer%26aufirst%3DThomas%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D34%26spage%3D7960%26epage%3D7980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Fa-Qian  Shen</span>, <span class="hlFld-ContribAuthor ">Meng-Ru  Yang</span>, <span class="hlFld-ContribAuthor ">Ling-Xia  You</span>, <span class="hlFld-ContribAuthor ">Li-Zhi  Chen</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>, <span class="hlFld-ContribAuthor ">Ya-Dong  Lu</span>, <span class="hlFld-ContribAuthor ">Fan-Lei  Kong</span>, <span class="hlFld-ContribAuthor ">Ming-Hua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (23-24)
                                     , 3816-3821. <a href="https://doi.org/10.1016/j.bmcl.2018.05.004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDihydropyrazothiazole%252Bderivatives%252Bas%252Bpotential%252BMMP-2%25252FMMP-8%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DWang%26aufirst%3DZhong-Chang%26date%3D2018%26volume%3D28%26issue%3D23-24%26spage%3D3816%26epage%3D3821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Hohn</span>, <span class="hlFld-ContribAuthor ">Mayland  Chang</span>, <span class="hlFld-ContribAuthor ">Jayda E.  Meisel</span>, <span class="hlFld-ContribAuthor ">Emma  Frost</span>, <span class="hlFld-ContribAuthor ">Katrin  Schwegmann</span>, <span class="hlFld-ContribAuthor ">Sven  Hermann</span>, <span class="hlFld-ContribAuthor ">Michael  Schäfers</span>, <span class="hlFld-ContribAuthor ">Burkhard  Riemann</span>, <span class="hlFld-ContribAuthor ">Günter  Haufe</span>, <span class="hlFld-ContribAuthor ">Hans‐Jörg  Breyholz</span>, <span class="hlFld-ContribAuthor ">Stefan  Wagner</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Preliminary
              In Vitro
              and
              In Vivo
              Evaluation of Thiirane‐Based Slow‐Binding MMP Inhibitors as Potential Radiotracers for PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (42)
                                     , 11729-11736. <a href="https://doi.org/10.1002/slct.201803093" title="DOI URL">https://doi.org/10.1002/slct.201803093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803093%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BPreliminary%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEvaluation%252Bof%252BThiirane%2525E2%252580%252590Based%252BSlow%2525E2%252580%252590Binding%252BMMP%252BInhibitors%252Bas%252BPotential%252BRadiotracers%252Bfor%252BPET%252BImaging%26aulast%3DHohn%26aufirst%3DMichael%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D42%26spage%3D11729%26epage%3D11736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. A. Jalil  Miah</span>, <span class="hlFld-ContribAuthor ">Mukund P.  Sibi</span>, <span class="hlFld-ContribAuthor ">S.  Chattopadhyay</span>, <span class="hlFld-ContribAuthor ">Oluwole B.  Familoni</span>, <span class="hlFld-ContribAuthor ">Victor  Snieckus</span>. </span><span class="cited-content_cbyCitation_article-title">Directed
              ortho
              -Metalation of
              O
              -Aryl
              N
              ,
              N
              -Dialkylcarbamates: Methodology, Anionic
              ortho
              -Fries Rearrangement, and Lateral Metalation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (4)
                                     , 440-446. <a href="https://doi.org/10.1002/ejoc.201701142" title="DOI URL">https://doi.org/10.1002/ejoc.201701142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701142%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirected%252Bortho%252B-Metalation%252Bof%252BO%252B-Aryl%252BN%252B%25252C%252BN%252B-Dialkylcarbamates%25253A%252BMethodology%25252C%252BAnionic%252Bortho%252B-Fries%252BRearrangement%25252C%252Band%252BLateral%252BMetalation%26aulast%3DMiah%26aufirst%3DM.%2BA.%2BJalil%26date%3D2018%26date%3D2017%26volume%3D2018%26issue%3D4%26spage%3D440%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Gelatinase inhibitors: a patent review (2011-2017). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 31-46. <a href="https://doi.org/10.1080/13543776.2018.1397132" title="DOI URL">https://doi.org/10.1080/13543776.2018.1397132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1397132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1397132%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DGelatinase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282011-2017%252529%26aulast%3DLi%26aufirst%3DXun%26date%3D2018%26date%3D2017%26volume%3D28%26issue%3D1%26spage%3D31%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Zhong</span>, <span class="hlFld-ContribAuthor ">Yu-Ting  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Zhi-Hao  Shi</span>, <span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Yu-Ping  Tang</span>, <span class="hlFld-ContribAuthor ">Jin-Ao  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2018,</strong> <em>13 </em>
                                    (1)
                                     , 75-87. <a href="https://doi.org/10.1080/17460441.2018.1398732" title="DOI URL">https://doi.org/10.1080/17460441.2018.1398732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2018.1398732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2018.1398732%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Bopportunities%252Bin%252Bmatrix%252Bmetalloproteinase%252Binhibitor%252Bdrug%252Bdesign%252Bfor%252Bcancer%26aulast%3DZhong%26aufirst%3DYue%26date%3D2018%26date%3D2017%26volume%3D13%26issue%3D1%26spage%3D75%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayda E.  Meisel</span>, <span class="hlFld-ContribAuthor ">Mayland  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2017,</strong> <em>1864 </em>
                                    (11)
                                     , 2001-2014. <a href="https://doi.org/10.1016/j.bbamcr.2017.04.011" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2017.04.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2017.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2017.04.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3DSelective%252Bsmall-molecule%252Binhibitors%252Bas%252Bchemical%252Btools%252Bto%252Bdefine%252Bthe%252Broles%252Bof%252Bmatrix%252Bmetalloproteinases%252Bin%252Bdisease%26aulast%3DMeisel%26aufirst%3DJayda%2BE.%26date%3D2017%26volume%3D1864%26issue%3D11%26spage%3D2001%26epage%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María  Font</span>, <span class="hlFld-ContribAuthor ">Daniel  Plano</span>, <span class="hlFld-ContribAuthor ">Carmen  Sanmartín</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Palop</span>. </span><span class="cited-content_cbyCitation_article-title">Topological and quantum molecular descriptors as effective tools for analyzing cytotoxic activity achieved by a series of (diselanediyldibenzene-4,1-diylnide)biscarbamate derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2017,</strong> <em>73 </em>, 62-73. <a href="https://doi.org/10.1016/j.jmgm.2017.01.016" title="DOI URL">https://doi.org/10.1016/j.jmgm.2017.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2017.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2017.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DTopological%252Band%252Bquantum%252Bmolecular%252Bdescriptors%252Bas%252Beffective%252Btools%252Bfor%252Banalyzing%252Bcytotoxic%252Bactivity%252Bachieved%252Bby%252Ba%252Bseries%252Bof%252B%252528diselanediyldibenzene-4%25252C1-diylnide%252529biscarbamate%252Bderivatives%26aulast%3DFont%26aufirst%3DMar%25C3%25ADa%26date%3D2017%26volume%3D73%26spage%3D62%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Fong  Tsai</span>, <span class="hlFld-ContribAuthor ">Shun-Chin  Yang</span>, <span class="hlFld-ContribAuthor ">Tsong-Long  Hwang</span>. </span><span class="cited-content_cbyCitation_article-title">Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (10)
                                     , 1139-1156. <a href="https://doi.org/10.1080/13543776.2016.1216546" title="DOI URL">https://doi.org/10.1080/13543776.2016.1216546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2016.1216546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2016.1216546%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFormyl%252Bpeptide%252Breceptor%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252Band%252Bpotential%252Bapplications%252Bfor%252Binflammatory%252Bdiseases%252B%2525282012-2015%252529%26aulast%3DTsai%26aufirst%3DYung-Fong%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D10%26spage%3D1139%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Gao</span>, <span class="hlFld-ContribAuthor ">Trung T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Mark A.  Suckow</span>, <span class="hlFld-ContribAuthor ">William R.  Wolter</span>, <span class="hlFld-ContribAuthor ">Major  Gooyit</span>, <span class="hlFld-ContribAuthor ">Shahriar  Mobashery</span>, <span class="hlFld-ContribAuthor ">Mayland  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2015,</strong> <em>112 </em>
                                    (49)
                                     , 15226-15231. <a href="https://doi.org/10.1073/pnas.1517847112" title="DOI URL">https://doi.org/10.1073/pnas.1517847112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1517847112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1517847112%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DAcceleration%252Bof%252Bdiabetic%252Bwound%252Bhealing%252Busing%252Ba%252Bnovel%252Bprotease%2525E2%252580%252593anti-protease%252Bcombination%252Btherapy%26aulast%3DGao%26aufirst%3DMing%26date%3D2015%26date%3D2015%26volume%3D112%26issue%3D49%26spage%3D15226%26epage%3D15231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bridgette D.  Semple</span>, <span class="hlFld-ContribAuthor ">Linda J.  Noble-Haeusslein</span>, <span class="hlFld-ContribAuthor ">Major  Gooyit</span>, <span class="hlFld-ContribAuthor ">Kayleen G.  Tercovich</span>, <span class="hlFld-ContribAuthor ">Zhihong  Peng</span>, <span class="hlFld-ContribAuthor ">Trung T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Valerie A.  Schroeder</span>, <span class="hlFld-ContribAuthor ">Mark A.  Suckow</span>, <span class="hlFld-ContribAuthor ">Mayland  Chang</span>, <span class="hlFld-ContribAuthor ">Jacob  Raber</span>, <span class="hlFld-ContribAuthor ">Alpa  Trivedi</span>, . </span><span class="cited-content_cbyCitation_article-title">Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , e0143386. <a href="https://doi.org/10.1371/journal.pone.0143386" title="DOI URL">https://doi.org/10.1371/journal.pone.0143386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0143386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0143386%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DEarly%252BGelatinase%252BActivity%252BIs%252BNot%252Ba%252BDeterminant%252Bof%252BLong-Term%252BRecovery%252Bafter%252BTraumatic%252BBrain%252BInjury%252Bin%252Bthe%252BImmature%252BMouse%26aulast%3DSemple%26aufirst%3DBridgette%2BD.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3De0143386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatriz  Romano</span>, <span class="hlFld-ContribAuthor ">Daniel  Plano</span>, <span class="hlFld-ContribAuthor ">Ignacio  Encío</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Palop</span>, <span class="hlFld-ContribAuthor ">Carmen  Sanmartín</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (8)
                                     , 1716-1727. <a href="https://doi.org/10.1016/j.bmc.2015.02.048" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.02.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.02.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIn%252Bvitro%252Bradical%252Bscavenging%252Band%252Bcytotoxic%252Bactivities%252Bof%252Bnovel%252Bhybrid%252Bselenocarbamates%26aulast%3DRomano%26aufirst%3DBeatriz%26date%3D2015%26volume%3D23%26issue%3D8%26spage%3D1716%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marilena  Tauro</span>, <span class="hlFld-ContribAuthor ">Jeremy  McGuire</span>, <span class="hlFld-ContribAuthor ">Conor C.  Lynch</span>. </span><span class="cited-content_cbyCitation_article-title">New approaches to selectively target cancer-associated matrix metalloproteinase activity. </span><span class="cited-content_cbyCitation_journal-name">Cancer and Metastasis Reviews</span><span> <strong>2014,</strong> <em>33 </em>
                                    (4)
                                     , 1043-1057. <a href="https://doi.org/10.1007/s10555-014-9530-4" title="DOI URL">https://doi.org/10.1007/s10555-014-9530-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10555-014-9530-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10555-014-9530-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520and%2520Metastasis%2520Reviews%26atitle%3DNew%252Bapproaches%252Bto%252Bselectively%252Btarget%252Bcancer-associated%252Bmatrix%252Bmetalloproteinase%252Bactivity%26aulast%3DTauro%26aufirst%3DMarilena%26date%3D2014%26date%3D2014%26volume%3D33%26issue%3D4%26spage%3D1043%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nian-Guang  Li</span>, <span class="hlFld-ContribAuthor ">Yu-Ping  Tang</span>, <span class="hlFld-ContribAuthor ">Jin-Ao  Duan</span>, <span class="hlFld-ContribAuthor ">Zhi-Hao  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Matrix metalloproteinase inhibitors: a patent review (2011 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (9)
                                     , 1039-1052. <a href="https://doi.org/10.1517/13543776.2014.937424" title="DOI URL">https://doi.org/10.1517/13543776.2014.937424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.937424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.937424%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMatrix%252Bmetalloproteinase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282011%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DLi%26aufirst%3DNian-Guang%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D9%26spage%3D1039%26epage%3D1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reuven  Reich</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Eli  Breuer</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Microenvironment as Target in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 269-284. <a href="https://doi.org/10.1016/B978-0-12-800167-7.00017-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-800167-7.00017-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800167-7.00017-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800167-7.00017-1%26sid%3Dliteratum%253Aachs%26atitle%3DTumor%252BMicroenvironment%252Bas%252BTarget%252Bin%252BCancer%252BTherapy%26aulast%3DReich%26aufirst%3DReuven%26date%3D2014%26spage%3D269%26epage%3D284%26pub%3DElsevier%26date%3D2014%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of the Carbonate and Carbamate Derivatives of <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and condition: (a) TEA, alkyl chloroformate, MeCN, 76–93%; (b) CuI, Cs<sub>2</sub>CO<sub>3</sub>, <i>N</i>,<i>N</i>-dimethylglycine HCl salt, 1,4-dioxane, 110 °C, 24 h, 83%; (c) HCl, MeOH, reflux, 1 h, 99%; (d) TEA, PNP-chloroformate, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; (e) MeNH<sub>2</sub>, THF, room temperature, 30 min, 67% from <b>11</b>; (f) TEA, alkyl isocyanate, dry toluene, reflux, 3 h, 93–98%; (g) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temperature, 6 d, 50–55%; (h) thiourea, MeOH/CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 24 h, 76–90%.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of the Urea and Carbamate Derivatives of <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and condition: (a) PNP-chloroformate, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; (b) MeNH<sub>2</sub>, THF, room temperature, 15 min, 53% from <b>3</b>; (c) NMM, alkyl isocyanate, THF, room temperature, 24 h, 55–61%; (d) NMM, alkyl chloroformate, THF, 0 °C, 20 min, 49–80%.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Stereo view of the thiirane analogues (<b>4b</b>, <b>5b</b>, <b>6b</b>, <b>7b</b>) docked to MMP-2 using Glide SP methodology. The ligands are represented in gray carbon capped stick representation, while MMP-2 carbon atoms and ribbons are colored aquamarine. Zn<sup>2+</sup> is depicted as a gray sphere with coordinating histidines and glutamic acid as capped sticks. Connolly surface in green was generated for MMP-2 except for the loop and zinc coordinating residues for clarity. (B) Compounds superposed to the MMP-14 crystal structure catalytic site (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2">3MA2</a>) show the bulkier amino acids Gln262 and Met264 substituted at the S1′ selectivity loop region in comparison to Thr426 and Thr428 in MMP-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Metabolic Pathways of Selected Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Product-ion mass spectra of (A) parent compound <b>5b</b> and metabolites (B) <b>M1</b>, (C) <b>M2</b>, and (D) <b>M3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Product-ion mass spectra of (A) parent compound <b>7a</b> and metabolites (B) <b>M4</b>, (C) <b>M5</b>, and (D) <b>M6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/medium/jm-2013-01217d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Brain and plasma concentration–time curves of (A) compound <b>2</b> after a single 25 mg/kg sc dose of compound <b>5b</b> to mice and (B) compound <b>6b</b> after a single 25 mg/kg sc dose of compound <b>6b</b> to mice. Concentrations in pmol/mg tissue for brain and in μM for plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401217d/production/images/large/jm-2013-01217d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401217d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Fokas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodel, C.</span><span> </span><span class="NLM_article-title">Biology of brain metastases and novel targeted therapies: time to translate the research</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1835</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1835&publication_year=2013&pages=61-75&author=E.+Fokasauthor=J.+P.+Steinbachauthor=C.+Rodel&title=Biology+of+brain+metastases+and+novel+targeted+therapies%3A+time+to+translate+the+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFokas%26aufirst%3DE.%26aulast%3DSteinbach%26aufirst%3DJ.%2BP.%26aulast%3DRodel%26aufirst%3DC.%26atitle%3DBiology%2520of%2520brain%2520metastases%2520and%2520novel%2520targeted%2520therapies%253A%2520time%2520to%2520translate%2520the%2520research%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1835%26spage%3D61%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Barnholtz-Sloan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigneau, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, R. E.</span><span> </span><span class="NLM_article-title">Incidence proportions of brain metastases in patients diagnosed (1973–2001) in the Metropolitan Detroit Cancer Surveillance System</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2865</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1200%2FJCO.2004.12.149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=15254054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=2865-2872&author=J.+S.+Barnholtz-Sloanauthor=A.+E.+Sloanauthor=F.+G.+Davisauthor=F.+D.+Vigneauauthor=P.+Laiauthor=R.+E.+Sawaya&title=Incidence+proportions+of+brain+metastases+in+patients+diagnosed+%281973%E2%80%932001%29+in+the+Metropolitan+Detroit+Cancer+Surveillance+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System</span></div><div class="casAuthors">Barnholtz-Sloan Jill S; Sloan Andrew E; Davis Faith G; Vigneau Fawn D; Lai Ping; Sawaya Raymond E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2865-72</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">PURPOSE:  Population-based estimates of the incidence of brain metastases are not generally available.  The purpose of this study was to calculate population-based incidence proportions (IPs) of brain metastases from single primary lung, melanoma, breast, renal, or colorectal cancer.  PATIENTS AND METHODS:  Patients diagnosed with single primary lung, melanoma, breast, renal, or colorectal cancer (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System (MDCSS) were used for analysis.  IP of brain metastases by primary site and variable of interest (race, sex, age at diagnosis of primary cancer, and Surveillance, Epidemiology, and End Results [SEER] stage of primary cancer) was calculated with 95% CIs.  RESULTS:  Total IP percentage (IP%) of brain metastases was 9.6% for all primary sites combined, and highest for lung (19.9%), followed by melanoma (6.9%), renal (6.5%), breast (5.1%), and colorectal (1.8%) cancers.  Racial differences were seen with African Americans demonstrating higher IP% of brain metastases compared with other racial groups for most primary sites.  IP% was significantly higher for female patients with lung cancer, and significantly higher for male patients with melanoma.  The highest IP% of brain metastases occurred at different ages at diagnoses: age 40 to 49 years for primary lung cancer; age 50 to 59 years for primary melanoma, renal, or colorectal cancers; and age 20 to 39 for primary breast cancer.  IP% significantly increased as SEER stage of primary cancer advanced for all primary sites.  CONCLUSION:  Total IP% of brain metastases was lower than previously reported, and it varied by primary site, race, sex, age at diagnosis of primary cancer, and SEER stage of primary cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1FltY_UquSCCEBeYuoi7AfW6udTcc2eYNKpVKLjlhuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltFWnuw%253D%253D&md5=76fa82deca39e5aced5f3d98735be3d0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.12.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.12.149%26sid%3Dliteratum%253Aachs%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%2BS.%26aulast%3DSloan%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DF.%2BG.%26aulast%3DVigneau%26aufirst%3DF.%2BD.%26aulast%3DLai%26aufirst%3DP.%26aulast%3DSawaya%26aufirst%3DR.%2BE.%26atitle%3DIncidence%2520proportions%2520of%2520brain%2520metastases%2520in%2520patients%2520diagnosed%2520%25281973%25E2%2580%25932001%2529%2520in%2520the%2520Metropolitan%2520Detroit%2520Cancer%2520Surveillance%2520System%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D2865%26epage%3D2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Xie, T. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldape, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershenwald, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Activation of stat3 in human melanoma promotes brain metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">3188</span><span class="NLM_x">–</span> <span class="NLM_lpage">3196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=3188-3196&author=T.+X.+Xieauthor=F.+J.+Huangauthor=K.+D.+Aldapeauthor=S.+H.+Kangauthor=M.+Liuauthor=J.+E.+Gershenwaldauthor=K.+Xieauthor=R.+Sawayaauthor=S.+Huang&title=Activation+of+stat3+in+human+melanoma+promotes+brain+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%2BX.%26aulast%3DHuang%26aufirst%3DF.%2BJ.%26aulast%3DAldape%26aufirst%3DK.%2BD.%26aulast%3DKang%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DGershenwald%26aufirst%3DJ.%2BE.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DSawaya%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DActivation%2520of%2520stat3%2520in%2520human%2520melanoma%2520promotes%2520brain%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D3188%26epage%3D3196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Preusser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilhan-Mutlu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berghoff, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartsch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zielinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span> </span><span class="NLM_article-title">Brain metastases: pathobiology and emerging targeted therapies</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1007%2Fs00401-011-0933-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BC38XpslyrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2012&pages=205-222&author=M.+Preusserauthor=D.+Capperauthor=A.+Ilhan-Mutluauthor=A.+S.+Berghoffauthor=P.+Birnerauthor=R.+Bartschauthor=C.+Marosiauthor=C.+Zielinskiauthor=M.+P.+Mehtaauthor=F.+Winklerauthor=W.+Wickauthor=A.+von+Deimling&title=Brain+metastases%3A+pathobiology+and+emerging+targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metastases: pathobiology and emerging targeted therapies</span></div><div class="casAuthors">Preusser, Matthias; Capper, David; Ilhan-Mutlu, Ayseguel; Berghoff, Anna Sophie; Birner, Peter; Bartsch, Rupert; Marosi, Christine; Zielinski, Christoph; Mehta, Minesh P.; Winkler, Frank; Wick, Wolfgang; Deimling, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-222</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Brain metastases (BM) are common in cancer patients and are assocd. with high morbidity and poor prognosis, even after intensive multimodal therapy including resection, radiotherapy (stereotactic radiosurgery or whole brain radiotherapy) and chemotherapy.  However, advances in the understanding of the pathobiol. of BM and the development of mol. targeted agents hold promise for improved prophylaxis and therapy of BM.  Here we provide a comprehensive review of the current concepts on mechanisms of the brain-metastatic cascade involving hematogenous dissemination of tumor cells, attachment to microvessel endothelial cells, extravasation into the brain, interaction with the local microenvironment, angiogenesis and intraparenchymal proliferation.  Transendothelial migration depends on adhesion mols. such as integrins, selectins and chemokines.  Tumor cells invade the brain by degrading extracellular matrix components using heparanase and matrix metalloproteinases.  Astrocytes and microglial cells exert not only anti-, but also pro-neoplastic effects on brain-invading tumor cells.  Some tumor types (e.g. melanoma) show prominent cooption of preexisting vasculature, while other tumor types (e.g. lung cancer) tend to show early angiogenesis after brain invasion.  In this article we also critically summarize the data on currently studied targeted therapeutics in BM esp. in the context of recent preclin. data.  The most promising agents for BM patients include anti-angiogenic drugs, inhibitors of v-RAF murine sarcoma viral oncogene homolog B1 (BRAF) for BRAF V600E mutated melanoma and inhibitors of epithelial growth factor receptor for non-small cell lung cancer.  Mol. anal. of the BRAF V600E status of melanoma BM using DNA-based methods or immunohistochem. may soon enter the routine neuropathol. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8umy2B0yazLVg90H21EOLACvtfcHk0lijALYphIHYsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpslyrsA%253D%253D&md5=6051d737b186cde4c307ff2a91b58af7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00401-011-0933-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-011-0933-9%26sid%3Dliteratum%253Aachs%26aulast%3DPreusser%26aufirst%3DM.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DIlhan-Mutlu%26aufirst%3DA.%26aulast%3DBerghoff%26aufirst%3DA.%2BS.%26aulast%3DBirner%26aufirst%3DP.%26aulast%3DBartsch%26aufirst%3DR.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DZielinski%26aufirst%3DC.%26aulast%3DMehta%26aufirst%3DM.%2BP.%26aulast%3DWinkler%26aufirst%3DF.%26aulast%3DWick%26aufirst%3DW.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DBrain%2520metastases%253A%2520pathobiology%2520and%2520emerging%2520targeted%2520therapies%26jtitle%3DActa%2520Neuropathol.%26date%3D2012%26volume%3D123%26spage%3D205%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">Blood–brain barrier delivery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=54-61&author=W.+M.+Pardridge&title=Blood%E2%80%93brain+barrier+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520delivery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D54%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscher, W.</span><span> </span><span class="NLM_article-title">The blood–brain barrier and cancer: transporters, treatment, and Trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663-1674&author=J.+F.+Deekenauthor=W.+Loscher&title=The+blood%E2%80%93brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+Trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0lijALYphIHYsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DLoscher%26aufirst%3DW.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520Trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Taskar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudraraju, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittapalli, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsheim, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gril, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Q. R.</span><span> </span><span class="NLM_article-title">Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1007%2Fs11095-011-0601-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=22011930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleqsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=770-781&author=K.+S.+Taskarauthor=V.+Rudrarajuauthor=R.+K.+Mittapalliauthor=R.+Samalaauthor=H.+R.+Thorsheimauthor=J.+Lockmanauthor=B.+Grilauthor=E.+Huaauthor=D.+Palmieriauthor=J.+W.+Polliauthor=S.+Castellinoauthor=S.+D.+Rubinauthor=P.+R.+Lockmanauthor=P.+S.+Steegauthor=Q.+R.+Smith&title=Lapatinib+distribution+in+HER2+overexpressing+experimental+brain+metastases+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer</span></div><div class="casAuthors">Taskar, Kunal S.; Rudraraju, Vinay; Mittapalli, Rajendar K.; Samala, Ramakrishna; Thorsheim, Helen R.; Lockman, Julie; Gril, Brunilde; Hua, Emily; Palmieri, Diane; Polli, Joseph W.; Castellino, Stephen; Rubin, Stephen D.; Lockman, Paul R.; Steeg, Patricia S.; Smith, Quentin R.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">770-781</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Lapatinib, a small mol. EGFR/HER2 inhibitor, partially inhibits the outgrowth of HER2+ brain metastases in preclin. models and in a subset of CNS lesions in clin. trials of HER2+ breast cancer.  We investigated the ability of lapatinib to reach therapeutic concns. in the CNS following 14C-lapatinib administration (100 mg/kg p.o. or 10 mg/kg, i.v.) to mice with MDA-MD-231-BR-HER2 brain metastases of breast cancer.  Drug concns. were detd. at differing times after administration by quant. autoradiog. and chromatog.  14C-Lapatinib concn. varied among brain metastases and correlated with altered blood-tumor barrier permeability.  On av., brain metastasis concn. was 7-9-fold greater than surrounding brain tissue at 2 and 12 h after oral administration.  However, av. lapatinib concn. in brain metastases was still only 10-20% of those in peripheral metastases.  Only in a subset of brain lesions (17%) did lapatinib concn. approach that of systemic metastases.  No evidence was found of lapatinib resistance in tumor cells cultured ex vivo from treated brains.  Results show that lapatinib distribution to brain metastases of breast cancer is partially restricted and blood-tumor barrier permeability is a key component of lapatinib therapeutic efficacy which varies between tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVPEpwl616crVg90H21EOLACvtfcHk0lijALYphIHYsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleqsLbN&md5=93de4680e8dcd3b0ee065ac002948ab7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs11095-011-0601-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-011-0601-8%26sid%3Dliteratum%253Aachs%26aulast%3DTaskar%26aufirst%3DK.%2BS.%26aulast%3DRudraraju%26aufirst%3DV.%26aulast%3DMittapalli%26aufirst%3DR.%2BK.%26aulast%3DSamala%26aufirst%3DR.%26aulast%3DThorsheim%26aufirst%3DH.%2BR.%26aulast%3DLockman%26aufirst%3DJ.%26aulast%3DGril%26aufirst%3DB.%26aulast%3DHua%26aufirst%3DE.%26aulast%3DPalmieri%26aufirst%3DD.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DCastellino%26aufirst%3DS.%26aulast%3DRubin%26aufirst%3DS.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DQ.%2BR.%26atitle%3DLapatinib%2520distribution%2520in%2520HER2%2520overexpressing%2520experimental%2520brain%2520metastases%2520of%2520breast%2520cancer%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D770%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandya, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilner, K. D.</span><span> </span><span class="NLM_article-title">CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">e443</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=e443-445&author=D.+B.+Costaauthor=S.+Kobayashiauthor=S.+S.+Pandyaauthor=W.+L.+Yeoauthor=Z.+Shenauthor=W.+Tanauthor=K.+D.+Wilner&title=CSF+concentration+of+the+anaplastic+lymphoma+kinase+inhibitor+crizotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DPandya%26aufirst%3DS.%2BS.%26aulast%3DYeo%26aufirst%3DW.%2BL.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilner%26aufirst%3DK.%2BD.%26atitle%3DCSF%2520concentration%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520inhibitor%2520crizotinib%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3De443%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pardridge, W. M.</span><span> </span><span class="NLM_article-title">The blood–brain barrier: bottleneck in brain drug development</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=3-14&author=W.+M.+Pardridge&title=The+blood%E2%80%93brain+barrier%3A+bottleneck+in+brain+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardridge%26aufirst%3DW.%2BM.%26atitle%3DThe%2520blood%25E2%2580%2593brain%2520barrier%253A%2520bottleneck%2520in%2520brain%2520drug%2520development%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D3%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Page-McCaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ewald, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases and the regulation of tissue remodelling</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1038%2Fnrm2125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=17318226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=221-233&author=A.+Page-McCawauthor=A.+J.+Ewaldauthor=Z.+Werb&title=Matrix+metalloproteinases+and+the+regulation+of+tissue+remodelling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and the regulation of tissue remodelling</span></div><div class="casAuthors">Page-McCaw, Andrea; Ewald, Andrew J.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-233</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) were discovered because of their role in amphibian metamorphosis, yet they have attracted more attention because of their roles in disease.  Despite intensive scrutiny in vitro, in cell culture and in animal models, the normal physiol. roles of these extracellular proteases have been elusive.  Recent studies in mice and flies point to essential roles of MMPs as mediators of change and phys. adaptation in tissues, whether developmentally regulated, environmentally induced or disease assocd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGsYuEMGL7Vg90H21EOLACvtfcHk0lhquv6BQd9qwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D&md5=8c3655e653939cd016e2949c6b017e93</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrm2125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2125%26sid%3Dliteratum%253Aachs%26aulast%3DPage-McCaw%26aufirst%3DA.%26aulast%3DEwald%26aufirst%3DA.%2BJ.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520metalloproteinases%2520and%2520the%2520regulation%2520of%2520tissue%2520remodelling%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D221%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Egeblad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werb, Z.</span><span> </span><span class="NLM_article-title">New functions for the matrix metalloproteinases in cancer progression</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1038%2Fnrc745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=11990853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=161-174&author=M.+Egebladauthor=Z.+Werb&title=New+functions+for+the+matrix+metalloproteinases+in+cancer+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">New functions for the matrix metalloproteinases in cancer progression</span></div><div class="casAuthors">Egeblad, Mikala; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-174</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) have long been assocd. with cancer-cell invasion and metastasis.  This provided the rationale for clin. trials of MMP inhibitors, unfortunately with disappointing results.  We now know, however, that the MMPs have functions other than promotion of invasion, have substrates other than components of the extracellular matrix, and that they function before invasion in the development of cancer.  With this knowledge in hand, can we rethink the use of MMP inhibitors in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtDQGs5M_BzLVg90H21EOLACvtfcHk0lhquv6BQd9qwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1KktL8%253D&md5=56dd558362155cb25c9adbea4d478aa8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc745%26sid%3Dliteratum%253Aachs%26aulast%3DEgeblad%26aufirst%3DM.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DNew%2520functions%2520for%2520the%2520matrix%2520metalloproteinases%2520in%2520cancer%2520progression%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D161%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Devy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dransfield, D. T.</span><span> </span><span class="NLM_article-title">New strategies for the next generation of matrix-metalloproteinase inhibitors: selectively targeting membrane-anchored MMPs with therapeutic antibodies</span> <span class="citation_source-journal">Biochem. Res. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">191670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1GgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=191670&author=L.+Devyauthor=D.+T.+Dransfield&title=New+strategies+for+the+next+generation+of+matrix-metalloproteinase+inhibitors%3A+selectively+targeting+membrane-anchored+MMPs+with+therapeutic+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies</span></div><div class="casAuthors">Devy Laetitia; Dransfield Daniel T</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry research international</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191670</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MMP intervention strategies have met with limited clinical success due to severe toxicities.  In particular, treatment with broad-spectrum MMP-inhibitors (MMPIs) caused musculoskeletal pain and inflammation.  Selectivity may be essential for realizing the clinical potential of MMPIs.  Here we review discoveries pinpointing membrane-bound MMPs as mediators of mechanisms underlying cancer and inflammation and as possible therapeutic targets for prevention/treatment of these diseases.  We discuss strategies to target these therapeutic proteases using highly selective inhibitory agents (i.e., human blocking antibodies) against individual membrane-bound MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDe2cVRPsAcYhLSh9fo81bfW6udTcc2ebUm385GiqWHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252Fkt1GgsQ%253D%253D&md5=af13351ed768e100fc35dd2df5e51b7e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDevy%26aufirst%3DL.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26atitle%3DNew%2520strategies%2520for%2520the%2520next%2520generation%2520of%2520matrix-metalloproteinase%2520inhibitors%253A%2520selectively%2520targeting%2520membrane-anchored%2520MMPs%2520with%2520therapeutic%2520antibodies%26jtitle%3DBiochem.%2520Res.%2520Int.%26date%3D2011%26volume%3D2011%26spage%3D191670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleifeld, O.</span><span> </span><span class="NLM_article-title">Tumour microenvironment—opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&author=C.+M.+Overallauthor=O.+Kleifeld&title=Tumour+microenvironment%E2%80%94opinion%3A+validating+matrix+metalloproteinases+as+drug+targets+and+anti-targets+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lhtNFxocXT3-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DTumour%2520microenvironment%25E2%2580%2594opinion%253A%2520validating%2520matrix%2520metalloproteinases%2520as%2520drug%2520targets%2520and%2520anti-targets%2520for%2520cancer%2520therapy%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D227%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Talvensaari-Mattila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paakko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyhtya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Sequeiros, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpeenniemi-Hujanen, T.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">–</span> <span class="NLM_lpage">1162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1998&pages=1153-1162&author=A.+Talvensaari-Mattilaauthor=P.+Paakkoauthor=M.+Hoyhtyaauthor=G.+Blanco-Sequeirosauthor=T.+Turpeenniemi-Hujanen&title=Matrix+metalloproteinase-2+immunoreactive+protein%3A+a+marker+of+aggressiveness+in+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalvensaari-Mattila%26aufirst%3DA.%26aulast%3DPaakko%26aufirst%3DP.%26aulast%3DHoyhtya%26aufirst%3DM.%26aulast%3DBlanco-Sequeiros%26aufirst%3DG.%26aulast%3DTurpeenniemi-Hujanen%26aufirst%3DT.%26atitle%3DMatrix%2520metalloproteinase-2%2520immunoreactive%2520protein%253A%2520a%2520marker%2520of%2520aggressiveness%2520in%2520breast%2520carcinoma%26jtitle%3DCancer%26date%3D1998%26volume%3D83%26spage%3D1153%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Still, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autzen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamdy, F. C.</span><span> </span><span class="NLM_article-title">Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2000&pages=18-25&author=K.+Stillauthor=C.+N.+Robsonauthor=P.+Autzenauthor=M.+C.+Robinsonauthor=F.+C.+Hamdy&title=Localization+and+quantification+of+mRNA+for+matrix+metalloproteinase-2+%28MMP-2%29+and+tissue+inhibitor+of+matrix+metalloproteinase-2+%28TIMP-2%29+in+human+benign+and+malignant+prostatic+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DK.%26aulast%3DRobson%26aufirst%3DC.%2BN.%26aulast%3DAutzen%26aufirst%3DP.%26aulast%3DRobinson%26aufirst%3DM.%2BC.%26aulast%3DHamdy%26aufirst%3DF.%2BC.%26atitle%3DLocalization%2520and%2520quantification%2520of%2520mRNA%2520for%2520matrix%2520metalloproteinase-2%2520%2528MMP-2%2529%2520and%2520tissue%2520inhibitor%2520of%2520matrix%2520metalloproteinase-2%2520%2528TIMP-2%2529%2520in%2520human%2520benign%2520and%2520malignant%2520prostatic%2520tissue%26jtitle%3DProstate%26date%3D2000%26volume%3D42%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Koshiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosotani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, M.</span><span> </span><span class="NLM_article-title">Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1998&pages=642-650&author=T.+Koshibaauthor=R.+Hosotaniauthor=M.+Wadaauthor=Y.+Miyamotoauthor=K.+Fujimotoauthor=J.+U.+Leeauthor=R.+Doiauthor=S.+Ariiauthor=M.+Imamura&title=Involvement+of+matrix+metalloproteinase-2+activity+in+invasion+and+metastasis+of+pancreatic+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoshiba%26aufirst%3DT.%26aulast%3DHosotani%26aufirst%3DR.%26aulast%3DWada%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BU.%26aulast%3DDoi%26aufirst%3DR.%26aulast%3DArii%26aufirst%3DS.%26aulast%3DImamura%26aufirst%3DM.%26atitle%3DInvolvement%2520of%2520matrix%2520metalloproteinase-2%2520activity%2520in%2520invasion%2520and%2520metastasis%2520of%2520pancreatic%2520carcinoma%26jtitle%3DCancer%26date%3D1998%26volume%3D82%26spage%3D642%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Nomura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, Y.</span><span> </span><span class="NLM_article-title">Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1002%2F%28SICI%291097-0215%2819960220%2969%3A1%3C9%3A%3AAID-IJC3%3E3.0.CO%3B2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=8600068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADyaK28Xit1yntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1996&pages=9-16&author=H.+Nomuraauthor=N.+Fujimotoauthor=M.+Seikiauthor=M.+Maiauthor=Y.+Okada&title=Enhanced+production+of+matrix+metalloproteinases+and+activation+of+matrix+metalloproteinase+2+%28gelatinase+A%29+in+human+gastric+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas</span></div><div class="casAuthors">Nomura, Hidehiro; Fujimoto, Noboru; Seiki, Motoharu; Mai, Masayoshi; Okada, Yasunori</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">The authors examd. the prodn. and tissue localization of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in gastric carcinoma tissues.  MMP-1 (tissue collagenase), MMP-9 (gelatinase B) and TIMP-2 were immunolocalized in carcinoma cells and MMP-2 (gelatinase A) on tumor cell membranes, whereas no or little immunostaining for MMP-3 (stromelysin-1) and TIMP-1 was seen in carcinoma cells.  Stromal cells in carcinoma tissue were also pos. stained for these MMPs and TIMPs.  MMP-2 immunostaining was obsd. exclusively on advanced gastric carcinoma cells and correlated with vascular invasion by tumor cells.  Sandwich enzyme immunoassays revealed enhanced prodn. of MMP-1, MMP-2, MMP-3, MMP-9 and TIMP-1 by carcinoma tissues.  Gelatinolytic activities were higher in carcinoma samples than in normal controls.  Using gelatin zymog., active forms of MMP-2 and MMP-9 were more frequently detected in carcinoma tissue, and the activation rate of the zymogen of MMP-2 (proMMP-2), but not that of proMMP-9, correlated well with degree of local invasion and lymphatic permeation.  The data indicate an enhanced prodn. of 4 MMPs in gastric carcinoma tissue and suggest that activation of pro-MMP-2 may be a key step for spreading of gastric carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHyxUZ34uyrbVg90H21EOLACvtfcHk0lhzJDErLxwQ4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit1yntr8%253D&md5=50fb4fe51a46aef25117f60fe0fde311</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2819960220%2969%3A1%3C9%3A%3AAID-IJC3%3E3.0.CO%3B2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252819960220%252969%253A1%253C9%253A%253AAID-IJC3%253E3.0.CO%253B2-8%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DH.%26aulast%3DFujimoto%26aufirst%3DN.%26aulast%3DSeiki%26aufirst%3DM.%26aulast%3DMai%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26atitle%3DEnhanced%2520production%2520of%2520matrix%2520metalloproteinases%2520and%2520activation%2520of%2520matrix%2520metalloproteinase%25202%2520%2528gelatinase%2520A%2529%2520in%2520human%2520gastric%2520carcinomas%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1996%26volume%3D69%26spage%3D9%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rojiani, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alidina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojiani, A. M.</span><span> </span><span class="NLM_article-title">Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FktFyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=775-781&author=M.+V.+Rojianiauthor=J.+Alidinaauthor=N.+Espositoauthor=A.+M.+Rojiani&title=Expression+of+MMP-2+correlates+with+increased+angiogenesis+in+CNS+metastasis+of+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma</span></div><div class="casAuthors">Rojiani Mumtaz V; Alidina Janeen; Esposito Nicole; Rojiani Amyn M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">775-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMP) have been implicated in increased invasive and metastatic potential of tumors, possibly via interactions with the extracellular matrix and angiogenesis.  This study investigates the relationship between MMP-2 immunoexpression and angiogenesis in a series of lung carcinomas metastatic to the central nervous system (CNS).  Twenty eight metastatic carcinoma cases with adequate brain-tumor interface were identified from the archives at the Moffitt Cancer Center.  MMP-2 expression was determined by immunohistochemistry using an antibody directed against pro and active forms (NeoMarkers).  Similarly, microvessels were identified on parallel sections with anti-CD34 antibody (Biogenix).  Angiogenesis profiles within the tumor and at the CNS/tumor interface were morphometrically assessed by the Image Pro Plus image analysis system.  Briefly, CD34 positive vessels were quantitated and correlated with presence or absence of MMP-2 expression in the tumor.  Mean microvessel area (MMVA) and mean microvessel number (MMVN) were assessed within areas of brain-tumor interface and within the tumor and expressed as a ratio relative to the tumor.  Sixteen (57.14%) metastatic tumors were strongly immunoreac-tive for MMP-2, while 12 (42.86%) were negative.  MMP-2 positive tumors had a higher MMVA and MMVN ratio at the CNS/tumor interface in comparison to MMP-2 negative neoplasms.  MMP-2 expression thus appears to confer enhanced vascular proliferation particularly at the brain-tumor interface which would support the contention of enhanced capability of growth and invasion within the CNS, possibly modulated by MMP2.  The relationship between MMP-2 expression and angiogenesis has been previously reported and its biological and therapeutic implications remain the focus of investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTfWNW_HPIT7Z0d-O_J5C0AfW6udTcc2ebxEqZulgYsIbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FktFyqtA%253D%253D&md5=5df31e2962f61f3a2659a3d3a4b8322d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRojiani%26aufirst%3DM.%2BV.%26aulast%3DAlidina%26aufirst%3DJ.%26aulast%3DEsposito%26aufirst%3DN.%26aulast%3DRojiani%26aufirst%3DA.%2BM.%26atitle%3DExpression%2520of%2520MMP-2%2520correlates%2520with%2520increased%2520angiogenesis%2520in%2520CNS%2520metastasis%2520of%2520lung%2520carcinoma%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Brown, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardo, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotra, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Potent and selective mechanism-based inhibition of gelatinases</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">6799</span><span class="NLM_x">–</span> <span class="NLM_lpage">6800</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja001461n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=6799-6800&author=S.+Brownauthor=M.+M.+Bernardoauthor=Z.+H.+Liauthor=L.+P.+Kotraauthor=Y.+Tanakaauthor=R.+Fridmanauthor=S.+Mobashery&title=Potent+and+selective+mechanism-based+inhibition+of+gelatinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja001461n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001461n%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DLi%26aufirst%3DZ.%2BH.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520mechanism-based%2520inhibition%2520of%2520gelatinases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D6799%26epage%3D6800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Forbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llarrull, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossing, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1111%2Fj.1747-0285.2009.00881.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=19807733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=527-534&author=C.+Forbesauthor=Q.+Shiauthor=J.+F.+Fisherauthor=M.+Leeauthor=D.+Hesekauthor=L.+I.+Llarrullauthor=M.+Tothauthor=M.+Gossingauthor=R.+Fridmanauthor=S.+Mobashery&title=Active+site+ring-opening+of+a+thiirane+moiety+and+picomolar+inhibition+of+gelatinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases</span></div><div class="casAuthors">Forbes, Christopher; Shi, Qicun; Fisher, Jed F.; Lee, Mijoon; Hesek, Dusan; Llarrull, Leticia I.; Toth, Marta; Gossing, Michael; Fridman, Rafael; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">527-534</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">(±)-2-[(4-Phenoxyphenylsulfonyl)methyl]thiirane (1) is a potent and selective mechanism-based inhibitor of the gelatinase sub-class of the zinc-dependent matrix metalloproteinase family.  Inhibitor 1 has excellent activity in in vivo models of gelatinase-dependent disease.  We demonstrate that the mechanism of inhibition is a rate-limiting gelatinase-catalyzed thiolate generation via deprotonation adjacent to the thiirane, with concomitant thiirane opening.  A corollary to this mechanism is the prediction that thiol-contg. structures, related to thiirane-opened 1, will possess potent matrix metalloproteinase inhibitory activity.  This prediction was validated by the synthesis of the product of this enzyme-catalyzed reaction on 1, which exhibited a remarkable Ki of 530 pM against matrix metalloproteinase-2.  Thiirane 1 acts as a caged thiol, unmasked selectively in the active sites of gelatinases.  This mechanism is unprecedented in the substantial literature on inhibition of zinc-dependent hydrolases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4TF4L9ayFLVg90H21EOLACvtfcHk0lg2mQGsK4fDmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7nF&md5=11ec87b9c4ddd1627d67bf5fb4e43362</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00881.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00881.x%26sid%3Dliteratum%253Aachs%26aulast%3DForbes%26aufirst%3DC.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DLlarrull%26aufirst%3DL.%2BI.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DGossing%26aufirst%3DM.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DActive%2520site%2520ring-opening%2520of%2520a%2520thiirane%2520moiety%2520and%2520picomolar%2520inhibition%2520of%2520gelatinases%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D527%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villegas-Estrada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celenza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreitinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Metabolism of a highly selective gelatinase inhibitor generates active metabolite</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1111%2Fj.1747-0285.2007.00577.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=17927722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlart7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=371-382&author=M.+Leeauthor=A.+Villegas-Estradaauthor=G.+Celenzaauthor=B.+Boggessauthor=M.+Tothauthor=G.+Kreitingerauthor=C.+Forbesauthor=R.+Fridmanauthor=S.+Mobasheryauthor=M.+Chang&title=Metabolism+of+a+highly+selective+gelatinase+inhibitor+generates+active+metabolite"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of a highly selective gelatinase inhibitor generates active metabolite</span></div><div class="casAuthors">Lee, Mijoon; Villegas-Estrada, Adriel; Celenza, Giuseppe; Boggess, Bill; Toth, Marta; Kreitinger, Gloria; Forbes, Christopher; Fridman, Rafael; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">371-382</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">(4-Phenoxyphenylsulfonyl)methylthiirane (inhibitor 1) is a highly selective inhibitor of gelatinases (matrix metalloproteinases 2 and 9), which is showing considerable promise in animal models for cancer and stroke.  Despite demonstrated potent, selective, and effective inhibition of gelatinases both in vitro and in vivo, the compd. is rapidly metabolized, implying that the likely activity in vivo is due to a metabolite rather than the compd. itself.  To this end, metab. of inhibitor 1 was investigated in in vitro systems.  Four metabolites were identified by LC/MS-MS and the structures of three of them were further validated by comparison with authentic synthetic samples.  One metabolite, 4-(4-thiiranylmethanesulfonylphenoxy)phenol (I), was generated by hydroxylation of the terminal Ph group of 1.  This compd. was investigated in kinetics of inhibition of several matrix metalloproteinases.  This metabolite was a more potent slow-binding inhibitor of gelatinases (matrix metalloproteinase-2 and matrix metalloproteinase-9) than the parent compd. 1, but it also served as a slow-binding inhibitor of matrix metalloproteinase-14, the upstream activator of matrix metalloproteinase-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSVma4hIKVwrVg90H21EOLACvtfcHk0lg2mQGsK4fDmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlart7%252FN&md5=c4bda3a0e7559417a5932837d779797c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00577.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00577.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%26aulast%3DVillegas-Estrada%26aufirst%3DA.%26aulast%3DCelenza%26aufirst%3DG.%26aulast%3DBoggess%26aufirst%3DB.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DKreitinger%26aufirst%3DG.%26aulast%3DForbes%26aufirst%3DC.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DMetabolism%2520of%2520a%2520highly%2520selective%2520gelatinase%2520inhibitor%2520generates%2520active%2520metabolite%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2007%26volume%3D70%26spage%3D371%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gooyit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikejiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckow, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Selective water-soluble gelatinase inhibitor prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6676</span><span class="NLM_x">–</span> <span class="NLM_lpage">6690</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200566e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6676-6690&author=M.+Gooyitauthor=M.+Leeauthor=V.+A.+Schroederauthor=M.+Ikejiriauthor=M.+A.+Suckowauthor=S.+Mobasheryauthor=M.+Chang&title=Selective+water-soluble+gelatinase+inhibitor+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm200566e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200566e%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSchroeder%26aufirst%3DV.%2BA.%26aulast%3DIkejiri%26aufirst%3DM.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSelective%2520water-soluble%2520gelatinase%2520inhibitor%2520prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6676%26epage%3D6690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Bonfil, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trindade Filho, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osenkowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinni, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vessella, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cher, M. L.</span><span> </span><span class="NLM_article-title">Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.2353%2Fajpath.2007.060720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlOhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2007&pages=2100-2111&author=R.+D.+Bonfilauthor=Z.+Dongauthor=J.+C.+Trindade+Filhoauthor=A.+Sabbotaauthor=P.+Osenkowskiauthor=S.+Nabhaauthor=H.+Yamamotoauthor=S.+R.+Chinniauthor=H.+Zhaoauthor=S.+Mobasheryauthor=R.+L.+Vessellaauthor=R.+Fridmanauthor=M.+L.+Cher&title=Prostate+cancer-associated+membrane+type+1-matrix+metalloproteinase%3A+a+pivotal+role+in+bone+response+and+intraosseous+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth</span></div><div class="casAuthors">Bonfil, R. Daniel; Dong, Zhong; Carlos, J.; Filho, Trindade; Sabbota, Aaron; Osenkowski, Pamela; Nabha, Sanaa; Yamamoto, Hamilto; Chinni, Sreenivasa R.; Zhao, Huiren; Mobashery, Shahriar; Vessella, Robert L.; Fridman, Rafael; Cher, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2100-2111</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Membrane type 1-matrix metalloproteinase (MT1-MMP) is a major mediator of collagen I degrdn.  In human samples, we show that prostate cancer cells in skeletal metastases consistently express abundant MT1-MMP protein.  Because prostate cancer bone metastasis requires remodeling of the collagen-rich bone matrix, we investigated the role of cancer cell-derived MT1-MMP in an exptl. model of tumor-bone interaction.  MT1-MMP-deficient LNCaP human prostate cancer cells were stably transfected with human wild-type MT1-MMP (MT1wt).  Furthermore, endogenous MT1-MMP was down-regulated by small interfering RNA in DU145 human prostate cancer cells.  Intratibial tumor injection in severe combined immunodeficient mice was used to simulate intraosseous growth of metastatic tumors.  LNCaP-MT1wt cells produced larger osseous tumors than Neo control cells and induced osteolysis, whereas DU145 MT1-MMP-silenced transfectants induced osteogenic changes.  In vitro assays showed that MT1wt overexpression enhanced collagen I degrdn., whereas MT1-MMP-silencing did the opposite, suggesting that tumor-derived MT1-MMP may contribute directly to bone remodeling.  LNCaP-MT1wt-derived conditioned medium stimulated in vitro multinucleated osteoclast formation.  This effect was inhibited by osteoprotegerin, a decoy receptor for receptor activator of nuclear factor κB ligand, and by 4-[4-(methanesulfonamido) phenoxy] phenylsulfonyl methylthiirane, an MT1-MMP inhibitor.  Our findings are consistent with the hypothesis that prostate cancer-assocd. MT1-MMP plays a direct and/or indirect role in bone matrix degrdn., thus favoring intraosseous tumor expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQE2LrT2SA3rVg90H21EOLACvtfcHk0lgpfXfGLmOBoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlOhtbo%253D&md5=365fdb4af6479ebe715cc441456cc62b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2007.060720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2007.060720%26sid%3Dliteratum%253Aachs%26aulast%3DBonfil%26aufirst%3DR.%2BD.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DTrindade%2BFilho%26aufirst%3DJ.%2BC.%26aulast%3DSabbota%26aufirst%3DA.%26aulast%3DOsenkowski%26aufirst%3DP.%26aulast%3DNabha%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DChinni%26aufirst%3DS.%2BR.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DVessella%26aufirst%3DR.%2BL.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DCher%26aufirst%3DM.%2BL.%26atitle%3DProstate%2520cancer-associated%2520membrane%2520type%25201-matrix%2520metalloproteinase%253A%2520a%2520pivotal%2520role%2520in%2520bone%2520response%2520and%2520intraosseous%2520tumor%2520growth%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2007%26volume%3D170%26spage%3D2100%26epage%3D2111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikejiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimpel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espahbodi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumarasiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noll, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Structure–activity relationship for thiirane-based gelatinase inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300050b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=490-495&author=M.+Leeauthor=M.+Ikejiriauthor=D.+Klimpelauthor=M.+Tothauthor=M.+Espahbodiauthor=D.+Hesekauthor=C.+Forbesauthor=M.+Kumarasiriauthor=B.+C.+Nollauthor=M.+Changauthor=S.+Mobashery&title=Structure%E2%80%93activity+relationship+for+thiirane-based+gelatinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300050b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300050b%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%26aulast%3DIkejiri%26aufirst%3DM.%26aulast%3DKlimpel%26aufirst%3DD.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DEspahbodi%26aufirst%3DM.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DForbes%26aufirst%3DC.%26aulast%3DKumarasiri%26aufirst%3DM.%26aulast%3DNoll%26aufirst%3DB.%2BC.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520for%2520thiirane-based%2520gelatinase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D490%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Minkkila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myllymaki, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saario, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo-Melendez, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koskinen, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leppanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, T.</span><span> </span><span class="NLM_article-title">The synthesis and biological evaluation of para-substituted phenolic <i>N</i>-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2994-3008&author=A.+Minkkilaauthor=M.+J.+Myllymakiauthor=S.+M.+Saarioauthor=J.+A.+Castillo-Melendezauthor=A.+M.+Koskinenauthor=C.+J.+Fowlerauthor=J.+Leppanenauthor=T.+Nevalainen&title=The+synthesis+and+biological+evaluation+of+para-substituted+phenolic+N-alkyl+carbamates+as+endocannabinoid+hydrolyzing+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinkkila%26aufirst%3DA.%26aulast%3DMyllymaki%26aufirst%3DM.%2BJ.%26aulast%3DSaario%26aufirst%3DS.%2BM.%26aulast%3DCastillo-Melendez%26aufirst%3DJ.%2BA.%26aulast%3DKoskinen%26aufirst%3DA.%2BM.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DLeppanen%26aufirst%3DJ.%26aulast%3DNevalainen%26aufirst%3DT.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520para-substituted%2520phenolic%2520N-alkyl%2520carbamates%2520as%2520endocannabinoid%2520hydrolyzing%2520enzyme%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mayer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piedecoq, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schambel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidaluc, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbert, T.</span><span> </span><span class="NLM_article-title">New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3653</span><span class="NLM_x">–</span> <span class="NLM_lpage">3664</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm991121g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3653-3664&author=P.+Mayerauthor=P.+Brunelauthor=C.+Chaplainauthor=C.+Piedecoqauthor=F.+Calmelauthor=P.+Schambelauthor=P.+Chopinauthor=T.+Wurchauthor=P.+J.+Pauwelsauthor=M.+Marienauthor=J.+L.+Vidalucauthor=T.+Imbert&title=New+substituted+1-%282%2C3-dihydrobenzo%5B1%2C4%5Ddioxin-2-ylmethyl%29piperidin-4-yl+derivatives+with+alpha%282%29-adrenoceptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm991121g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991121g%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DP.%26aulast%3DBrunel%26aufirst%3DP.%26aulast%3DChaplain%26aufirst%3DC.%26aulast%3DPiedecoq%26aufirst%3DC.%26aulast%3DCalmel%26aufirst%3DF.%26aulast%3DSchambel%26aufirst%3DP.%26aulast%3DChopin%26aufirst%3DP.%26aulast%3DWurch%26aufirst%3DT.%26aulast%3DPauwels%26aufirst%3DP.%2BJ.%26aulast%3DMarien%26aufirst%3DM.%26aulast%3DVidaluc%26aufirst%3DJ.%2BL.%26aulast%3DImbert%26aufirst%3DT.%26atitle%3DNew%2520substituted%25201-%25282%252C3-dihydrobenzo%255B1%252C4%255Ddioxin-2-ylmethyl%2529piperidin-4-yl%2520derivatives%2520with%2520alpha%25282%2529-adrenoceptor%2520antagonist%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3653%26epage%3D3664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Pochetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gege, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taveras, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazza, F.</span><span> </span><span class="NLM_article-title">Extra binding region induced by non-zinc chelating inhibitors into the S1′ subsite of matrix metalloproteinase 8 (MMP-8)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1049</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801166j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1040-1049&author=G.+Pochettiauthor=R.+Montanariauthor=C.+Gegeauthor=C.+Chevrierauthor=A.+G.+Taverasauthor=F.+Mazza&title=Extra+binding+region+induced+by+non-zinc+chelating+inhibitors+into+the+S1%E2%80%B2+subsite+of+matrix+metalloproteinase+8+%28MMP-8%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm801166j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801166j%26sid%3Dliteratum%253Aachs%26aulast%3DPochetti%26aufirst%3DG.%26aulast%3DMontanari%26aufirst%3DR.%26aulast%3DGege%26aufirst%3DC.%26aulast%3DChevrier%26aufirst%3DC.%26aulast%3DTaveras%26aufirst%3DA.%2BG.%26aulast%3DMazza%26aufirst%3DF.%26atitle%3DExtra%2520binding%2520region%2520induced%2520by%2520non-zinc%2520chelating%2520inhibitors%2520into%2520the%2520S1%25E2%2580%25B2%2520subsite%2520of%2520matrix%2520metalloproteinase%25208%2520%2528MMP-8%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1040%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Gooyit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggess, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm401217d&amp;key=10.1111%2Fj.1747-0285.2009.00898.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm401217d&amp;key=19824893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=535-546&author=M.+Gooyitauthor=M.+Leeauthor=D.+Hesekauthor=B.+Boggessauthor=A.+G.+Oliverauthor=R.+Fridmanauthor=S.+Mobasheryauthor=M.+Chang&title=Synthesis%2C+kinetic+characterization+and+metabolism+of+diastereomeric+2-%281-%284-phenoxyphenylsulfonyl%29ethyl%29thiiranes+as+potent+gelatinase+and+MT1-MMP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors</span></div><div class="casAuthors">Gooyit, Major; Lee, Mijoon; Hesek, Dusan; Boggess, Bill; Oliver, Allen G.; Fridman, Rafael; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">535-546</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gelatinases (MMP-2 and MMP-9) have been implicated in a no. of pathol. conditions, including cancer and cardiovascular disease.  Hence, small mol. inhibitors of these enzymes are highly sought for use as potential therapeutic agents.  2-(4-Phenoxyphenylsulfonylmethyl)thiirane (SB-3CT) has previously been demonstrated to be a potent and selective inhibitor of gelatinases, however, it is rapidly metabolized because of oxidn. at the para position of the phenoxy ring and at the α-position to the sulfonyl group.  α-Me variants of SB-3CT were conceived to improve metabolic stability and as mechanistic probes.  We describe herein the synthesis and evaluation of these structural variants as potent inhibitors of gelatinases.  Two (compds. 5b and 5d) among the four synthetic stereoisomers were found to exhibit slow-binding inhibition of gelatinases and MMP-14 (MT1-MMP), which is a hallmark of the mechanism of this class of inhibitors.  The ability of these compds. to inhibit MMP-2, MMP-9, and MMP-14 could target cancer tissues more effectively.  Metab. of the newly synthesized inhibitors showed that both oxidn. at the α-position to the sulfonyl group and oxidn. at the para position of the terminal Ph ring were prevented.  Instead oxidn. on the thiirane sulfur is the only biotransformation pathway obsd. for these gelatinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxkzohVUsbXrVg90H21EOLACvtfcHk0lgyYkcTyzIujw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGku7bM&md5=53d801a92815933fe7f578d34c1f926e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00898.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00898.x%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DHesek%26aufirst%3DD.%26aulast%3DBoggess%26aufirst%3DB.%26aulast%3DOliver%26aufirst%3DA.%2BG.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520kinetic%2520characterization%2520and%2520metabolism%2520of%2520diastereomeric%25202-%25281-%25284-phenoxyphenylsulfonyl%2529ethyl%2529thiiranes%2520as%2520potent%2520gelatinase%2520and%2520MT1-MMP%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D74%26spage%3D535%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Gooyit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckow, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span> </span><span class="NLM_article-title">Selective gelatinase inhibitor neuroprotective agents cross the blood–brain barrier</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn300062w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=730-736&author=M.+Gooyitauthor=M.+A.+Suckowauthor=K.+L.+Schroederauthor=W.+R.+Wolterauthor=S.+Mobasheryauthor=M.+Chang&title=Selective+gelatinase+inhibitor+neuroprotective+agents+cross+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Gooyit, Major; Suckow, Mark A.; Schroeder, Valerie A.; Wolter, William R.; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">730-736</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SB-3CT, a potent and selective inhibitor of matrix metalloproteinase-2 and -9, has shown efficacy in several animal models of neurol. diseases.  One of the greatest challenges in the development of therapeutics for neurol. diseases is the inability of drugs to cross the blood-brain barrier.  A sensitive bioanal. method based on ultraperformance liq. chromatog. with multiple-reaction monitoring detection was developed to measure levels of SB-3CT, its active metabolite, the α-Me analog, and its p-hydroxy metabolite in plasma and brain.  The compds. are rapidly absorbed and are readily distributed to the brain.  The pharmacokinetic properties of these gelatinase inhibitors and the efficacy shown by SB-3CT in animal models of stroke, subarachnoid hemorrhage, and spinal cord injury indicate that this class of compds. holds considerable promise in the treatment of diseases of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmol4U6a2bIbVg90H21EOLACvtfcHk0lgyYkcTyzIujw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE&md5=05f147cd30e827b2d81b155af8a6c418</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn300062w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300062w%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DK.%2BL.%26aulast%3DWolter%26aufirst%3DW.%2BR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSelective%2520gelatinase%2520inhibitor%2520neuroprotective%2520agents%2520cross%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D730%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ikejiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardo, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfil, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title">Potent mechanism-based inhibitors for matrix metalloproteinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">33992</span><span class="NLM_x">–</span> <span class="NLM_lpage">34002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=33992-34002&author=M.+Ikejiriauthor=M.+M.+Bernardoauthor=R.+D.+Bonfilauthor=M.+Tothauthor=M.+Changauthor=R.+Fridmanauthor=S.+Mobashery&title=Potent+mechanism-based+inhibitors+for+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIkejiri%26aufirst%3DM.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DBonfil%26aufirst%3DR.%2BD.%26aulast%3DToth%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DPotent%2520mechanism-based%2520inhibitors%2520for%2520matrix%2520metalloproteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D33992%26epage%3D34002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, H. B.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1030</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1030-1037&author=P.+Taoauthor=J.+F.+Fisherauthor=Q.+Shiauthor=S.+Mobasheryauthor=H.+B.+Schlegel&title=Matrix+metalloproteinase+2+%28MMP2%29+inhibition%3A+DFT+and+QM%2FMM+studies+of+the+deprotonation-initialized+ring-opening+reaction+of+the+sulfoxide+analogue+of+SB-3CT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DP.%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DSchlegel%26aufirst%3DH.%2BB.%26atitle%3DMatrix%2520metalloproteinase%25202%2520%2528MMP2%2529%2520inhibition%253A%2520DFT%2520and%2520QM%252FMM%2520studies%2520of%2520the%2520deprotonation-initialized%2520ring-opening%2520reaction%2520of%2520the%2520sulfoxide%2520analogue%2520of%2520SB-3CT%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2009%26volume%3D114%26spage%3D1030%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm401217d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lgR-Q8WDFTmYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2','PDB','3MA2'); return false;">PDB: 3MA2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CK7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CK7','PDB','1CK7'); return false;">PDB: 1CK7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a href="/doi/suppl/10.1021/jm401217d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_58527"></div></div></div></div></div><hr /></hr><p class="last">Kinetic parameters for the slow-binding inhibition of MMPs; concentrations of compounds <b>2</b> and <b>6b</b> in plasma and brain.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401217d/suppl_file/jm401217d_si_001.pdf">jm401217d_si_001.pdf (174.17 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID for the TOC graphic <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MA2">3MA2</a> (MMP-14 coordinate), and PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CK7">1CK7</a> (MMP-2 coordinate).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401217d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm401217d%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-20" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401217d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aec971a2e199f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
